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KATHRYN BREYEL SPENCER. The role of FMRP in ethanol-induced
homeostatic plasticity in the hippocampus.
(Under the direction of L. Judson Chandler).
Exposure

to

chronic

ethanol

induces

homeostatic

alterations

in

glutamatergic signaling and actin polymerization that may have an important role
in the development of ethanol-seeking behaviors. Acute ethanol exposure
promotes excitation and dampens inhibition while extended periods of exposure
induce long-term adaptations in neuronal function that require new protein
synthesis to maintain homeostasis. These adaptations include not only
transcription and somatic protein synthesis, but also local dendritic protein
translation. One of the major mediators of activity-dependent translation is the
mTORC1 signaling pathway and its downstream substrates that include kinases
and mRNA-binding proteins, such as p70 S6 kinase 1 (S6K1) and fragile X
mental retardation protein (FMRP). FMRP is an mRNA-binding protein that
interacts with mRNAs to suppress translation. FMRP also interacts with several
different mRNAs that code for proteins that are necessary for synaptic plasticity,
and it may also have an important role in regulating ethanol-induced alterations
in homeostasis in dendrites and dendritic spines. This dissertation addresses the
hypothesis that FMRP is necessary for activity-dependent homeostatic
alterations in protein expression and spine morphology following chronic ethanol
exposure. First, western blot analysis was used to investigate ethanol-induced
alterations in expression of FMRP and proteins that are key mediators of

xv

dendritic

excitability.

These

studies

revealed

an

increase

in

FMRP

phosphorylation as well as alterations in the A-type K+-channel Kv4.2, KChIP3
and NMDA receptor subunits. Further studies examining changes in FMRP
interactions with Kv4.2, KChIP3, and NMDA mRNAs showed chronic ethanolinduced changes in FMRP-mRNA binding. Additionally, inhibition of FMRP
phosphorylation prevented these alterations in protein expression and FMRPmRNA interactions following chronic ethanol exposure. Studies included in this
dissertation also addressed whether alterations in protein expression are
accompanied by changes in actin polymerization and spine morphology. These
experiments utilized two different sub-strains of C57BL/6 mice with different
polymorphisms in cyfip2, a protein regulating actin polymerization that is also
implicated in regulation of protein translation. A two-bottle choice/CIE exposure
paradigm revealed alterations in ethanol consumption between the two strains as
well as differences in ethanol-induced changes in protein expression and spine
morphology. Taken together, this dissertation reveals an integral role for FMRP
in mediating ethanol-induced alterations in homeostatic protein expression, and
that these alterations may influence actin polymerization and drinking behaviors.
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Chapter 1

Background and Significance

Impact of ethanol dependence

In many industrialized nations, alcohol is consumed on a daily basis to
relieve stress and for its effects on positive mood states (Grant et al 2004). Like
coffee or nicotine, it has become a cultural norm at many social events. However,
overuse of alcohol presents several issues that have lasting effects on societal
as well as individual levels, and alcohol addiction continues to be a major social,
economic, and medical burden to communities worldwide. According to the

World Health Organization, alcohol is the third-largest risk factor for health
burden, and is the number one risk factor for middle-income countries (Dawson
and Grant 1998; Grant et al 2004; Bouchery et al 2011). In the United States,
alcohol use disorders are among the most prevalent mental health disorders
regardless of ethnicity or socioeconomic status and are the third leading cause of
death (Goetze et al 2003; Grant et al 2004). Economically, it has a significant toll
on the overall cost to society and the individual. The latest data available for
2006 revealed that alcohol accrued a total cost over $220 billion, owning to loss
of productivity, cost to the government, and expenses related to healthcare costs
and criminal activity (Bouchery et al 2011).
On the individual level as of 2006, approximately half of adults have a family
member with an alcohol use disorders (Boucher et al 2011; Dawson and Grant
2011). Addiction and the development of addictive behaviors involve a complex
gene x environment interaction that culminates in a pathology that is costly,
poorly understood, and difficult to treat (Goetze et al 2003; Grant 2000). Toxicity
from long-term, heavy drinking affects many different body systems and organs
from the liver and pancreas to the brain (Grant et al 2004; Bouchery et al 2011).
Without a discrete mechanism of action, it is difficult to elucidate the mechanisms
driving addictive behaviors and long-term effects of alcohol abuse, and therefore,
makes it difficult to treat.
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Ethanol’s effect on the hippocampus

Ethanol and hippocampal circuitry

Ethanol acts on a number of different organ systems, including the central
nervous system. In the brain, ethanol interacts with several brain regions, altering
neuronal function resulting in behavioral changes, following both acute and
chronic ethanol use (Gulick and Gould 2007; Zorumski et al 2014). These
behavioral effects are mediated not only by brain regions associated with reward
and executive function, such as the nucleus accumbens (Nac), ventral
tegemental area (VTA), and prefrontal cortex (PFC), but also areas mediating
emotion and memory, such as the amgydala and hippocampus, respectively
(Figure 1-1) (Zhou et al 2007; Heinz et al 2009; Bailey et al 2015).

The

interconnectivity of the hippocampus with other brains regions and its role in
learning and memory make this region an important intersection of reward and
cognition (Lynch 2003; Adcock et al 2006; Zorumski et al 2014). In other drugs of
abuse, differences in hippocampal function mediate not just acquisition of drugtaking, but also alters the time needed to induce reinstatement and relapse
(Castilla-Ortega et al 2015, Mague et al 2015). In alcohol abuse disorders, one of
the principal cognitive effects is the attenuation of learning and memory (Fadda
and Rossetti 1998; Roberto et al 2002; Spanagel 2009). This attenuation can
have lasting effects on the individual and a significant impact, both socially and
economically (Grant 2000; Grant et al 2004; Bouchery et al 2011).
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Ethanol’s effect on memory

Acute episodes of binge drinking that are accompanied by a rapid increase
in blood ethanol concentration can interfere with hippocampal-mediated episodic
memory formation (White et al 2000; Zorumski et al 2014). Following a bingedrinking episode, individuals can participate in salient and emotionally-charged
situations in the present, but cannot remember events that occurred shortly after
the drinking episode (Miller et al 1978; White et al 2000). Although most
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individuals do not sustain long-term complications after a period of prolonged
abstinence, some alcoholics do in fact develop permanent disabilities that require
lifetime care (Sullivan et al 1995, Makris et al 2008; Zorumski et al 2014). These
include memory-related disorders such as ethanol-induced persistent amnesia
caused by Wernicke-Korsakoffs syndrome. Although this loss of function was
originally attributed to thalamic and mammillary bodies dysfunction, more recent
studies implicate the hippocampus (Squire et al 1990, Sullivan and Marsh 2003,
Kurth et al 2004, Beresford et al 2006). Specifically, the loss of adult
neurogenesis and reduction in functional efficiency of the hippocampus in
processing information from other regions (Sullivan and March 2003; Adcock et
al 2006; Makris et al 2008). Wernick-Korsakoffs syndrome is the most wellcharacterized long-term deficit resulting from chronic ethanol exposure, other
more subtle deficits in hippocampal-dependent memory may also exist (Walter et
al 1980; Beresford et al 2006; Spanagel 2009). In adult men with a history of
long-term heavy alcohol use, total hippocampal volume was significantly reduced,
and this reduction is independent of total brain or intracranial volumes (Beresford
et al 2006; Makris et al 2008). This shrinkage was drastically increased among
Wernicke-Korsakoffs patients compared to non-amnesic alcoholics (Walker et al
1980; Agartz et al 1999; Sullivan and Marsh 2003).
The role for the hippocampus in ethanol-induced memory deficits and its
contribution to alcohol dependence is also an active area of preclinical alcohol
research studies. In nonhuman primates given free access to alcohol,
hippocampal volume was inversely correlated with drinking behaviors (Zhou et al
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2007; Kroenke et al 2014). Studies in rodent models of alcohol exposure show a
decrease in newly formed neurons in adult animals, suggesting in addition to
white matter, alcohol use may also alter cell proliferation and survival (Herrera et
al 2003; Anderson et al 2012; Talani et al 2013). Behaviorally, in rodent models,
alcohol-preferring rats show deficits in spatial learning during the Morris Water
Maze task (Santin et al 2000; White et al 2000). Although the hippocampus is not
generally thought of as mediating ethanol-mediated behaviors in terms of
ethanol-seeking or motivation, its role in salience and memory, along with the
long-term effects of chronic alcohol use, indicate an important overall role in
ethanol-induced short- and long-term behavioral deficits (Santin et al 2000 Gulick
and Gould 2007).
A number of environmental changes may induce alterations in the brain at
the behavioral, regional, and cellular level that allow for adaptation and
maintenance of homeostasis (Spanagel, 2009; Thomas et al 2013; Bailey et al
2015). In the hippocampus, like other areas of the brain, these cellular alterations
involve both pre- and postsynaptic events to remodel synaptic function to fit
these environmental changes (Davies et al 1989; Bliss and Collingridge 1993;
Bellot et al 2014). This includes reestablishing a balance between excitation and
inhibition to prevent hyperexcitability while also preserving proper neuronal
function, and actin polymerization and cytoskeletal remodeling to accommodate
alterations in cellular activity (Sutton et al 2006; Gal-Ben-Ari et al 2011; Thomas
et al 2013; Labno et al 2014; Baily et al 2015). In pyramidal neurons in the
hippocampus, this balance includes excitatory glutmatergic systems, inhibitory
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GABAergic influences, as well as local inhibitory proteins in axons, dendrites,
and dendritic spines (Lei et al 2008; Lei et al 2010; Enoch et al 2012; Korkotian
et al 2013).

The hippocampus as a model system

The hippocampus is often used in studies as a model system for exploring
the cellular mechanisms driving neuronal activity in different experimental
conditions. It is an essential component of learning and memory, and can have
significant effects on global brain function (Pastalkova et al 2006; Simons et al
2009). The hippocampus is also one of the brain regions that is highly
susceptible to damage, and its function is impaired in many different brain
diseases, including addiction, making it a useful region to study several aspects
of cellular function (Holopainen 2005; Korkotian et al 2013). The utility of this
region as a model system is due to the neuroanatomy, connectivity, and
cytoarchitecture (Turner 1959; Hsia et al 1998; Knierim 2002). Although the
hippocampus receives input from several brain regions, the main input
mechanism lies with the perforant pathway. This is a ‘one way’ circuit through the
perforate pathway to the dentate gyrus, then CA3 to the CA1 followed by the
major output through the subliculum (Hsia et al 1998; Knierim 2002). In vivo
models can readily assess hippocampal deficits with behavior paradigms, such
as the Morris water maze (Morris 1981; Vorhees and Williams 2006). In vitro
experiments can address neuronal mechanisms driving these behaviors. In
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organotypic hippocampal slice cultures the intra-regional connectivity, and
mature cytoarchitecture are preserved, and can be used for several weeks
(Stoppini et al 1991; Holopainen 2005). Taken together, these features make the
hippocampus a useful tool in elucidating and manipulating the cellular
mechanisms driving learning and memory as well as alcohol use disorders.

Glutmatergic signaling and NMDA receptors

NMDA receptor structure and kinetics

Ethanol directly interacts with a number of different cellular mechanisms
and proteins, including NMDA receptors, that induce alterations in neuronal
homeostasis (Lovinger et al 1990; Hendrickson et al 2004; Nagy 2008). NMDA
receptors, along with AMPA and kainate receptors are glutamate receptors that
promote excitation in the brain (Keinanen et al 1990; Nakanishi 1992; Dingledine
et al 1999). They are heteromeric ligand-gated ion channels that pass both Na

+

and Ca+2 ions, but NMDA receptors are five to ten times more permeable to
calcium than sodium (Hume et al 1991; Koh et al 1995; Mori and Mishina 1995;
Rosenmund et al 1998). The NMDA receptor itself is composed of two GluN1
subunits and two of GluN2A-D subunits. The GluN1 subunit is necessary for
trafficking to the membrane and contains the binding site for the co-agonist
glycine or D-serine (Benveniste and Mayer 1991; Mori and Mishina 1995;
Dingledine et al 1999; Hawkins et al 2004). GluN2 subunits determine channel
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kinetics and contain the glutamate-binding site (Hume et al 1991; Flint et al 1997;
Zhang et al 2013; Hansen et al 2014). Each channel has an extracellular domain
that contains a modulatory and ligand binding region for association with the
agonist and co-agonist, a membrane domain contributes to the channel that
conveys the high permeability to calcium, and the extensive cytoplasmic domain
that contains residues for direct modification by different kinases to alter channel
function and localization (Kuner et al 1996; Fong et al 2002; Hawkins et al 2004;
Chen and Roche 2007; Goebel-Goody et al 2009; Zhang et al 2013). These
channels may localize to the postsynaptic density or the extrasynaptic space
(Groc et al 2006; Goebel-Goody et al 2009; Groc et al 2009; Gladding and
Raymond 2011). Composition of the receptor and the stage of brain development
dictate the localization (Flint et al 1997; Barria and Malinow 2002; Groc et al
2007; Gladding and Raymond 2011). As the brain develops into adulthood, there
is the addition of GluN2A containing NMDA receptors, with GluN2A typically
trafficked to the postsynaptic density and GluN2B shuttled to the extrasynaptic
space (Ehlers et al 1995; Groc et al 2006; Akashi et al 2009; Groc et al 2009;
Gladding and Raymond 2011).
In addition to both an agonist and co-agonist, NMDA receptors also have a
voltage-gated Mg2+ ion site that blocks the channel pore (Mayer et al 1984;
Nowak et al 1984). For activation, the NMDA receptor must bind both glutamate
and glycine that is typically released from the presynaptic neuron while the
postsynaptic membrane is depolarized to remove the Mg2+ block (Mayer et al
1984; Nowak et al 1984; Seeberg et al 1995). Requiring both of these
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circumstances to occur pairs pre- and postsynaptic activity, and it is thought to be
important in coincidence detection; that is the coincidence of presynaptic
glutamate release and postsynaptic depolarization (Bliss and Lomo 1973; Davies
et al 1989; Kullman and Nicoll 1992; Markram et al 1997; Lauri et al 2007). The
concept of coincidence detection may have an important influence over neuronal
information by forming associations between two separate neuronal events that
are spatially separated, but temporally close that converge on a common point
(Davies et al 1989; Kullmann and Nicoll 1992; Bliss and Collingridge 1993). At
the cellular level, the paired mechanism for NMDA receptor activation may
represent the persistent activation needed to trigger the strengthening of
synapses between two neurons, and may also provide a potential synaptic model
for memory in the formed long-term potentiation (LTP) (Bliss and Lomo 1973;
Davies et al 1989; Bashir et al 1991; Bliss and Collingridge 2002; Lauri et al
2007).

LTP in the hippocampus

LTP is one of the most prominent hypothesized mechanisms for adaptive
synaptic plasticity, and is widely associated in the hippocampus with learning and
memory (Bliss and Collingridge 1993; Bliss and Colingridge 2013). As mentioned
previously, NMDA receptors are coincidence detectors and have important
implications for LTP and learning and memory (Davies et al 1989; Bashir et al
1991; Tsien et al 1996; Luthi et al 2001; Pastalkova et al 2006). This process has
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three properties: cooperativity, associativity, and specificity (Bliss et al 1977;
McNaughton et al 1978; Levy and Steward 1979; Bliss and Colingridge 1993;
Bliss and Collingridge 2013). Cooperativity describes the intensity of the
threshold needed to induce LTP (McNaughton et al 1978; Davies et al 1989;
Bliss and Collinridge 1993). While weak stimulation of a single pathway is
insufficient to produce LTP, it relies on appropriate threshold and timing of the
stimulus for LTP induction to occur (Bliss and Lomo 1973; Bliss and Collinridge
1993). Associativity of LTP states that a weak stimulus can be potentiated if a
separate, stronger signal converges on a single postsynaptic site (McNaughton
et al 1978; Levy and Steward 1979). Lastly, specificity refers to LTP input. That is,
LTP is specific for the active synapse, and synapses that are not active at the
same time and do not experience the appropriate stimulation will not induce the
mechanisms of LTP (Andersen et al 1977; Lynch et al 1977; Bliss and Collinridge
1993). These three properties are all under the assumption that this stimulation
occurs on an area of the dendrite that is already depolarized (Bliss and
Collinridge et al 1993; Lisman and Spruston 2005)
LTP can be divided into two different phases. The early phase in NMDAdependent LTP involves the opening of NMDA receptors and an influx of calcium
into the postsynaptic neuron, but does not require transcription or new protein
synthesis (Alford et al 1993; Bliss and Collingridge 1993; Emptage et al 1999).
This influx of calcium is the critical event for the induction of LTP (Alford et al
1993; Spruston et al 1995; Emptage et al 1999; Torras-Garcia 2005). However,
activation and calcium influx from NMDA receptors alone may not be enough to
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produce LTP. The NMDA receptor antagonist, AP-V inhibits LTP, but treatment
with thapsigarin also prevents LTP induction, suggesting that intracellular calcium
is also important (Harvey and Collingridge 1992; Mody and MacDonald 1995;
Emptage et al 1999).
Throughout

this

early

phase,

calcium-induced

activation

of

Ca2+/calmodulin-dependent protein kinase II (CaMKII) leads to increased
phosphorylation of NMDA receptors (Gnegy 2000; Hayashi et al 2000; Fong et al
2002; Lee et al 2009). This, in turn, causes an increase in surface-expressed
AMPA and increases the sodium permeability of the receptor that alters
membrane potential and kinetics (Malinow 2003; Fleming and England 2010;
Lisman et al 2012; Luscher and Malenka 2012). After the initial phosphorylation
of CaMKII, activation persists due to autophosphorylation (Giese et al 1998;
Lucic et al 2008). The late phase of LTP, unlike the early phase, requires
transcription of new mRNAs and somatic and dendritic translation of new protein
(Krug et al 1984; Frey et al 2001; Adams and Dudek 2005). Inhibition of protein
synthesis with the polyribosome inhibitor ansiomycin blocks late-phase LTP, but
does not alter LTP induction (Krug et al 1984; Bailey et al 2015).
This switch from early- to late-phase LTP involves the activation of several
different intracellular signaling cascades that are needed to shift from the
induction to the maintenance phase. These include both transcription and
translation factors that are necessary for the new protein synthesis needed
during late-phase LTP. Late-phase LTP activates CREB and corresponds with an
increase in CRE-mediated gene targets (Riccio and Ginty 2002; Panja et al 2014;
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Bailey et al 2015). Additionally, several downstream substrates of the ERK
pathway are also upregulated or activated (Kim et al 2005; Ivanov et al 2006;
Gladding and Raymond 2011). One of the main pathways responsible for local
dendritic translation is also activated, PI3-K, the upstream kinase for Akt and
mTORC1, is unregulated in the shift from early to late LTP (Tang et al 1999;
Gong et al 2006; Bekinschtein et al 2007; Dibble and Cantley 2015). Blockade of
PI3-K blocks the maintenance, but not induction of LTP (Brami-Cherrier et al
2002; Takei and Hiroyki 2014; Dibble and Cantley 2015).
In the hippocampus, the behavioral manifestations of LTP have been
heavily investigated. Inhibition of LTP, either early- or late-phase, is associated
with blockade of hippocampal-dependent behaviors (Torras-Garcia 2005;
Kleykamp et al 2010). Rats injected with AP-V perform poorly on the Morris water
maze compared to vehicle controls, and this attentuation of spatial learning
corresponds to the blockade of cellular activity associated with LTP (Morris et al
1986, Zalutsky and Nicoll 1990; Hanse and Gustafsson 1992; Tsien et al 1996).
However, blockade of NMDA receptors seems particularly important during the
acquisition phase of memory. Pretraining on the Morris water maze does not
produce inhibition of LTP or impair performance, but lack of experience prevents
memory acquisition (Bannerman et al 1995). It also appears that NMDAdependent LTP is particularly important for certain types of memory. NMDA
activation is the main receptor responsible for induction of LTP in most, but not
all areas of the brain (Johnston et al1992; Torras-Garcia 2005). Mice with
increases in total NMDA receptor protein or increased GluN2B subunit
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expression show enhanced LTP (Tang et al 1999; Rinaldi et al 2007; Wang et al
2009). Disruption of LTP via inhibition of NMDA receptor activity leads to normal
tone-dependent fear learning that is not dependent on hippocampal function, but
impairments of context fear learning, which does rely on the hippocampus (Stiedl
et al 2000; Torras-Garcia 2005; Kim et al 2006: Robert and Hunt 2015).
Additionally, inhibition of other components downstream of the initial acquisition
phase of LTP and learning also impair LTP and hippocampal-dependent memory
(Zhao et al 2005; Lynch 2003; Niewoehner et al 2007). Inhibition or deletion of
CaMKII produces hippocampal-dependent learning deficits in spatial memory
and impairs LTP (Strack et al 2000; Kasai et al 2003; Bliss and Collingridge
2013).
Enhancement of LTP and memory is also associated with alterations in the
actin cytoskeleton and spine morphology (Fukazawa et al 2003). LTP causes
spine enlargement and is associated with long-term spine stabilization to a
mature phenotype (Tolias et al 2005; Hill and Zito 2013; Bellot et al 2014;
Cingolani and Goda 2008; Lemphrecht 2014). This change in morphology may
have an important role in maintaining the strengthened synapses (Spacek et al
1997; Lynch 2003; Nageri et al 2004; Bellot et al 2014). This change can be
characterized by alterations in spine shape, number, and density, and throughout
most of the hippocampus, these changes are dependent on NMDA activation
and induction of late phase LTP (Engert and Bonhoeffer 1999; Hill and Zito 2013;
Lamprecht 2014). Like the electrophysiological properties of LTP, CaMKII is also
an important regulator of spine morphology during LTP (Okamoto et al 2007;
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Kasai et al 2003). CaMKII mediates several actin-binding proteins, and CaMKII
knockout animals or knockdown of CaMKII with shRNA produces deficits in not
only LTP and learning, but also induces an immature spine phenotype that is
resistant to activity-dependent changes in morphology (Sobczyk et al 1995;
Strack et al 2000; Okamoto et al 2007; Cingolani and Goda 2008).

NMDA receptors and chronic ethanol use

Glutamatergic synapses, LTP, and dendritic spines are all important
components of hippocampal-mediated behavior and are also altered following
chronic ethanol exposure (Lovinger et al 1990; Nestler 2001; Nagy 2011). NMDA
receptors in particular are susceptible to ethanol-induced alterations in
expression and activity. In the context of alcohol use, these receptors have
differential responses to acute and chronic ethanol, and may have an important
role in ethanol-induced hyperexcitability (Lovinger 1993; Tsai and Coyle 1998;
Gulick et al 2007). Acutely, ethanol dose-dependently inhibits NMDA receptors to
rapidly decrease peak-current amplitude and accelerates the rate of current
desensitization, decreases open channel probability, and these changes occur in
a dose-dependent manner (Lovinger et al 1989; Gass and Olive 2008;
Moykkynen and Korpi 2012). Previous studies indicate preferential inhibition for
either GluN2A- or GluN2B-containing NMDA receptors (Blevins et al 1997; Nagy
2011). However, this may also be region specific, as other studies indicate
preferences for GluN2B-containing receptors (Masood et al 1994; Du et al 2011).
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Inhibition of NMDA receptors with MK-801 potentiates acute ethanol-induced
impairment in memory tasks (Camarini et al 2000). Although ethanol partially
blocks NMDA receptors, this is effective in producing the ‘blackouts’ seen with
acute exposure as well as longer, deficits in LTP and behavioral tasks examining
hippocampal-dependent memory (Miller et al 1994; Lukoyanov et al 2000;
Kleykamp et al 2010; Bisby et al 2015; Robert and Hunt 2015). In addition, dosedependent effects on pyramidal cell NMDA suppression correlates with dosedependent effects on episodic memory in rodent studies (Santin et al 2000;
White and Best 2000; Tokuda et al 2007). Rats exposed to ethanol also have
impaired performance on hippocampal-dependent memory tasks, such as the
Morris water maze (Lukoyanov et al 2000; Schulteis et al 2008; Robert and Hunt
2015).
Clinical studies also show that this effect on NMDA receptors alters not only
hippocampal-dependent memory, but also translates into effects in neuronal
function. Individuals with long-term ethanol use show a selective increase in
mRNA levels for the NMDA glutamate receptor in the hippocampus (Hall and
Zador 1997; Birnir et al 2014; Jin et al 2014). Other preclinical studies in rats and
mice exposed to chronic intermittent ethanol have shown an increase in surfaceexpressed GluN2B- containing NMDA receptors and NMDA-mediated current
during chronic ethanol exposure (Trevisan et al 1994; Follesa and Ticku 1996;
Kumari and Ticku 2000). This increase is characterized by a shift in GluN2Bcontaining NMDA receptors from the extrasynaptic space into the postsynaptic
density (Carpenter-Hyland et al 2004; Akashi et al 2009). Functionally, this may
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have an important role in ethanol-induced hyperexcitability and lead to toxicity
and neuronal death upon ethanol-withdrawal (Mody and MacDonald 1995;
Hendricson et al 2007; Lau and Zukin 2007; Haft et al 2014).
Ethanol’s effect on NMDA receptors also effects ethanol-induced
excitotoxicity during acute withdrawal after cessation of ethanol use following
chronic exposure. Ethanol dependence that results in withdrawal can occur even
after short bouts of chronic ethanol abuse (Macey et al 1996; Hall and Zador
1997). This withdrawal syndrome is characterized by both behavioral and cellular
effects that increase excitability (Roberto et al 2002; Anderson et al 2012)
Repeated bouts of ethanol withdrawal potentiates withdrawal hyperexcitability in
the hippocampus and results in ‘kindling’ of withdrawal seizures (Duka et al 2004;
Pawlak et al 2005). Previous studies have found that withdrawal toxicity due to
chronic ethanol use is associated with an increase in NMDA receptor expression
and function (Roberto et al, 2001, Hendricson et al, 2007). This includes an
increase in GluN1 expression in dendritic spines in the CA1 (Pian et al 2010).
Activation of NMDA receptors is necessary for seizure activity; blockade of the
receptor with AP-V or MK-801 prevents ethanol-induced withdrawal (Chandler et
al 1993; Camarini et al 2000; Hendricson et al 2007).
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Proteins regulating glutamatergic signaling

Role of Kv4.2 Channels in Neuronal Excitation

In addition to proteins regulating excitatory input, ethanol also alters
proteins that balance excitation with inhibition. One important mediator of
neuronal excitation in dendrites and dendritic spines is the voltage-gated K+channel Kv4.2. Kv4.2 is a sub-threshold channel that carries A-type current that
is part of the Shal-family of K+-channels (Birnbaum et al 2004; Jerng et al 2004;
Leung 2010; Barros et al 2012) Like all A-type K+- channels, Kv4.2 produces an
outward, transient K+- current that rapidly inactivates, and inactivation and
recovery occur at sub-threshold membrane potential (Jerng et al 2004; Barros et
al 2012; Carrasquillo et al 2012). These channels form either homo- or
heteromultimeric complexes with the alpha subunits forming the pore of the
channel and modulatory beta subunits creating a complete channel. Kv4.2 has 6
transmembrane domains with a conserved P-loop, which is shared by many K+channels and function in K+ recognition, while the fourth transmembrane domain
serves as the voltage sensor (Serodio and Rudy 1998; Orlova et al 2003;
Birnbaum et al 2004; Jerng et al 2004; Ren et al 2005).
Shal-family K+- channels are expressed throughout the central nervous
system as well as the heart, where they also help to modulate excitation and
maintain function (Rasmusson et al 1998; Jerng et al 2004; Zhou et al 2004;
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Kaufmann et al 2012; Carraquillo et al 2012). Expression of Kv4.2 channels in
the hippocampus increases with distance from the soma, and are highly
concentrated around dendritic branch points in the extrasynaptic space (Cai et al
2004; Kim et al 2007; Kerti et al 2012, Nester and Hoffman 2011; Kaufmann et al
2012). The location and kinetic properties of these channels make them
important regulators of back propagating action potentials, compartmentalization
of activity in dendrites, firing frequency, and spike repolarization (Serodio and
Rudy 1998; Kim et al 2007; Carrasquillo et al 2012).
Kv4.2 channels also form complexes with auxiliary proteins that modulate
channel surface expression and kinetics to form a fully functional channel. Each
auxiliary subunit conveys different kinetic properties to the channel. One auxiliary
subunit, dipeptidyl-aminopeptidase-like protein 6 (DPP6), interacts with Kv4.2
near the first transmembrane domain, and accelerates channel recovery time
(Rhodes et al 2004; Ren et al 2005, Leung 2010; Barros et al 2012; Lin et al
2014; Bezerra et al 2015; Kitazawa et al 2015). Another group of proteins known
as K+-channel interacting proteins 1-4 (KChIP 1-4), and are particularly important
for Kv4.2 expression and function, especially in the hippocampus, interact with all
Shal-family K+- channels (An et al 2000; Lin et al 2004; Li et al 2006; Lin et al
2010; Kunjilwar et al 2013). These proteins determine not only inactivation time,
but also rate of depolarization, and promote K+-channel surface expression (Lin
et al 2004; Menegola et al 2006; Ruiz-Gomez et al 2006; Lin et al 2010; Norris et
al 2010). Although these channels do not require these auxiliary components for
surface expression, Kv4.2 must interact with at least one of two subtypes of
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proteins for the channel to function (Rhodes et al 2004; Li et al 2006; Attali et al
2009; Lin et al 2010; Norris et al 2010; Kitazawa et al 2015).
In addition to auxiliary subunits, Kv4.2 activity is also mediated through
post-translational modifications that fine tune channel function based on intra- or
extracellular changes in activity (Anderson et al 2000; Jerng et al 2004; Barros et
al 2012). Phosphorylation of Kv4.2 at different sites by different kinases alters
different components of channel function, and these changes are also
determined by cellular location, such as distance from the soma (Varga et al
2004; Hammond et al 2008; Kerti et al 2012; Nestor and Hoffman, 2012).
Phosphorylation by CaMKII increases Kv4.2-mediated A-type current through an
increase in Kv4.2 surface expression (Varga et al 2004; Labna et al 2014). Kv4.2
has three potential regulatory sites for phosphorylation via the ERK/MAPK
pathway (Adams et al 2000; Schrader et al 2002; Schrader et al 2006; Lin et al
2010). At one threonine site, phosphorylation decreases current (Adams et al
2000; Schrader et al 2006; Labno et al 2014). At another site, Kv4.2 current is
increased, but this requires the inclusion of KChIP3 specifically in the
macromolecular complex (Schrader et al 2006; Kim et al 2007; Kunjilwar et al
2013). As previously mentioned, Kv4.2 distribution varies, depending on distance
from the soma (Cai et al 2004; Kerti et al 2012, Nester and Hoffman 2011;
Kaufmann et al 2012). This distance also dictates turnover rate of the channel.
Increasing the distance also increases the turnover rate through phosphorylation
by PKA, and this turnover rate is activity-dependent (Schrader et al 2002;
Hammond et al 2008, Monaghan et al 2008; Nester and Hoffman 2011).
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Kv4.2 channels, LTP, and learning

Kv4.2 channels also have an important influence over NMDA receptors in
controlling hyperexcitability, especially in the hippocampus. Deletion of Kv4.2 in
knockout animals or through viral knockdown increases the expression of
GluN2B-containing NMDA receptors and the induction of LTP (Chen et al 2006,
Kaufmann et al 2012; Lugo et al 2012). Conversely, an increase in A-type current
through activation of Kv4.2 channels decreases GluN2B-containing NMDA
receptors (Kaufmann et al 2012; Korkotian et al 2013). This increase in Kv4.2
activation is dependent on calcium influx through NMDA receptors specifically
and the activity of CaMKII, and can be blocked by inhibition of GluN2B- but not
GluN2A- containing NMDA receptors (Jung et al 2008, Lei et al 2010, Kaufmann
et al 2012; Labna et al 2014). NMDA receptors may also mediate Kv4.2
expresssion. Downregulation of Kv4.2 channels is dependent on GluN2Bcontaining NMDA receptors (Lei et al 2008; Lei et al 2010). As such, Kv4.2 may
remodel synapses and this balance between excitation an inhibition may have an
influential role in ethanol-induced hyperexcitability.
This effect on GluN2B-containing NMDA receptors may have an important
role in altering learning and hippocampal-dependent behaviors, such as spatial
memory and temporal lobe epilepsy (Leung et al 2010, Kaufmann et al 2012,
Labna et al 2014). Kv4.2 channels in the hippocampus are of great interest due
to their role in regulating NMDA-mediated hyperexcitability and LTP (Lei and Xu
2008; Lei et al 2010). Previous studies have shown both deficient and enhanced
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LTP in Kv4.2 knockout animals (Chen et al 2006; Kaufmann et al 2012). These
studies revealed that deletion of Kv4.2 results in deficits in the learning phase of
the Morris water maze, and these deficits are not attributed to differences in
GABAergic function (Lugo et al 2012). Blockade of Kv4.2 also impairs
performance on the radial arm maze task, and this performance is restored after
channels are fully functional (Labna et al 2014). In addition, learning
hippocampal-dependent memory tasks have been shown to promote an increase
in expression of Kv4.2 mRNA in dendrites and dendritic spines (Petrecca et al
2000; Gross et al 2011; Trucket et al 2012). Interestingly, this is not associated
with an increase in total protein expression, but rather may ensure maintenance
of protein expression and activity-dependent changes throughout the learning
process (Ruschenschmidt et al 2006; Trucket et al 2012; Labno et al 2014).
At the cellular level, it is hypothesized that Kv4.2 channels alter long, but
not short term plasticity (Andrasfalvy et al 2008; Truchet et al 2012). Their
influence over NMDA-dependent LTD may modulate signal to noise ratios to
optimize the appropriate synaptic connections to facilitate learning and memory
and fine-tune excitability in neuronal networks (Lei and Xu 2008; Labno et al
2014). Selective increases or decreases in Kv4.2 expression or function in
certain populations of neurons may be key for proper function in the learning and
memory network, and may be an essential component of hippocampaldependent memory tasks and cognition (Shen et al 2008; Prince and Ring 2011;
Truchet et al 2012). Due to its role in excitability, Kv4.2 is also an important
mediator of other hippocampal-dependent behaviors and diseases. Formation of
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Kv4.2 complexes and proper channel function are necessary for proper
integration of synaptic signaling and activity-induced neuroplasticity (Lin et al
2004; Jung et al 2008; Leung 2010; Labna et al 2014).
As a therapeutic target in neurodegenerative disorders, blockade of Kv4.2
prevents the loss of K+, decreases intracellular apoptotic processes, and
decreases neuronal cell death (Ruschenschmidt et al 2006; Leung et al 2010).
Temporal lobe epilepsy is associated with long-term decreases in Kv4.2, and this
change in expression parallels the acquisition of recurrent seizures (Monaghen et
al 2008; Su et al 2008). Therapeutic agents that enhance channel opening are
effective in altering epileptic seizures and decreasing interictal activity (Lugo et al
2008; Aronica et al 2009; Leung et al 2010). Animal models with both pilocarineor kainic acid- induced seizures, show a long-term decrease in surfaceexpressed Kv4.2 channels (Jung et al 2008, Su et al 2008). Kv4.2 knockout mice
have increased pilocarpine-induced seizures and are prone to excitotoxic
neuronal death (Barnwell et al 2009).

KChIP3’s regulation of Kv4.2

As mentioned above, Kv4.2 channels require auxiliary proteins for optimal
channel function. Both DPPX and KChIPs interact with Kv4.2, but KChIP
interactions with the channel have a larger effect on channel kinetics and function
(An et al 2004; Lin et al 2004; Rhodes 2004; Callsen et al 2005; Kitazawa et al
2015). KChIPs are EF- hand calcium sensors, and subtypes 1-4 contain 4
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calcium sensor domains on the conversed C-terminus and a divergent Nterminus (Spreafico et al 2001; Callsen et al 2005; Barghann et al 2008; Woo et
al 2008; Mikhaylova et al 2011). Of particular interest in regulating excitability and
activity-dependent hippocampal function is KChIP3. Each KChIP has its
‘preferred’ binding partner, and has a somewhat discrete regional and cellular
expression pattern (Rhodes et al 2004; Xiong et al 2004; Menegola et al 2006).
Although, KChIP2 is the most widely expressed of the four subtypes, based on
results from co-immunoprecipitation studies, KChIP3 is the preferential binding
partner of Kv4.2 (Xiong et al 2004; Han et al 2006; Menegola et al 2006). The
difference in the N-terminus of the four KChIPs is responsible for the variation in
Shal-family channel kinetics with different KChIPs (Callsen et al 2005; Barghann
et al 2008; Raghuram et al 2012). Phosphorylation of KChIP3 induces KChIP3Kv4.2 interaction, but this alone is not enough to induce Kv4.2 to be trafficked to
the membrane, and palmitoylation of KChIP3 is also required for localization to
the surface (Takimoto 2002).
Functionally, KChIP3 binds to Kv4.2 as an intracellular auxiliary unit to
convey specific gating properties, channel kinetics, and promote surface
expression (Shibata et al 2003; Menegola et al 2006; Woo et al 2008; Norris et al
2010). The conserved C-terminus of the KChIPs, in addition serving as the
calcium-binding region, also interact with the alpha pore-forming subunit Kv4.2
(Spreafico et al 2001; Shibata et al 2003; Han et al 2006). However, the Nterminus gives different properties to the channel (Hopkins et al 1994; Callsen et
al 2005; Han et al 2006). KChIP3 interaction with Kv4.2 produces more rapid
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depolarization and faster inactivation, compared with other KChIP subtypes
(Kunjilwar et al 2004; Norris et al 2010). Decreasing KChIP3 expression through
viral knockdown decreases Kv4.2 channel surface expression and Kv4.2mediated A-type current, even in the presence of KChIP2 (Menegola et al 2006;
Norris et al 2010). Likewise, decreasing Kv4.2 expression in the hippocampus is
also associated with a reduction in KChIP3 expression (Menegola and Trimmer
2006). The other auxiliary subunit, DPP6, does not produce a surface-expressed
channel with optimal function without KChIP3 interaction (Norris et al 2010). They
retain the ability to pass current, but are significantly reduced in the absence of
KChIPs. However, KChIP3 interaction alone with Kv4.2 channels, results in a
current that is lower in amplitude than that of a channel possessing both DPP6
and KChIP3 (Norris et al 2010; Kitazawa et al 2015). Functionally, this interaction
between KChIP3 and Kv4.2 has important implications in behavior and pathology.
KChIP3 knockout animals have decreased Kv4.2-mediated A-type current as
well as decreased performance on memory tasks such as novel object
recognition (Wu et al 2008; Alexander et al 2009).
In addition to its role with Kv4.2, KChIP3 was also discovered in two other
fields of research. It was independently discovered as downstream regulatory
element antagonist modulator (DREAM) and calsenilin (Buxbaum et al 1998;
Carrión et al 1999). DREAM in a transcriptional regulator that binds to
downstream regulatory elements (DRE) to suppress transcription (Carrion et al
1999; Mellstrom et al 2001; Mellstrom et al 2014). The C-terminus of DREAM
serves as the DRE-DREAM interaction domain with DRE, and binding of calcium
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induces dimerization of DREAM and translocation to the nucleus (Carrion et al
1999; Osawa et al 2001; Woo et al 2008; Ramachandran et al 2012). In the
nucleus, DREAM must drop off the bound calcium to all three EF-hand domains
(Craig et al 2002; Woo et al 2008; Mellstrom et al 2014). DREAM has also been
shown to be an important regulator of a number of different mRNAs, including
prodynorphin and cFos (Spreafico et al 2012; Alexander et al 2009). Mice
overexpressing a calcium insensitive form of DREAM (tg-DREAM), have
increased levels of prodynorphin compared to knockouts, and have an response
to activity-dependent changes in cFos protein expression (Spreafico et al 2001;
Dierssen and Naranjo 2012).
Due to its role as a dynorphin regulator, DREAM was intensively studied as
a potential therapeutic target for chronic pain (Cheng et al 2002; Costigan and
Woolf 2002, Cheng and Penninger 2004). DREAM knockout mice have a higher
pain tolerance compared to control mice that accompany this increase in
dynorphin expression (Cheng et al 2002). However, the complexity of its
involvement in other activity-dependent mechanisms, and its diffuse nuclear and
somatodendritic expression pattern makes it difficult to manipulate as a
pharmacological target for a phenotype that is limited to only one of its functions
(Cheng and Penninger 2004; Woo et al 2008; Alexander et al 2009). Although all
four KChIP proteins have a conserved C-terminus and are capable of binding
DRE sequences, none of the other subtypes localize to the nucleus. In yeast-two
hybrid studies, when any of the four subtypes are expressed in the nucleus, all
show DRE sequence interactions and serve as a transcriptional repressor
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(Pruunslid and Timmusk 2005; Raghuram et al 2012). However, animal models
show knockdown of KChIP3, not the other three subtypes, alter mRNAs whose
corresponding gene contains the specified DRE sequence (Woo et al 2008;
Pruunslid and Timmusk 2012).
In addition to DREAM, KChIP3 was also described separately as calsenilin.
Calsenilin interacts with presenilin, the active subunit of the enzyme gamma
amlyase, which synthesizes beta amyloid (Buxbaum et al 1998; Lilliehook et al
2003). Through interaction with this subunit, calsenilin regulates the rate of
conversion and the type of beta amyloid made (Fontan-Lozano et al 2009; Craig
et al 2013). The role of calsenilin in beta amyloid production has lead to an
interest in its role in the pathology of Alzheimer’s disease (Dong-Gyu et al 2004;
Alexander et al 2009; Craig et al 2013). Calsenilin also interacts with other
intracellular mediators to regulate apoptosis and intracellular Ca2+ release from
the endoplasmic reticulum (Leissring et al 2000; Lilliehook et al 2002).
Localization of KChIP3 within the cell is important in regulating cellular
processes and behavior. In animals overexpressing a calcium-insensitive
KChIP3 it is unable to act as a transcription factor, and as a result there is less
localization to the nucleus (Dierssen and Naranjo 2012). While these animals
show normal LTP, they display enhanced contextual fear conditioning (Wu et al
2010, Alexander et al 2009). However, in patients with Alzheimer’s disease,
KChIP3 expression is elevated which may be associated with a decline in
cognitive function as well as an increase in apoptosis (Lilliehook et al 2002; Craig
et al 2013). In the context of epilepsy, there is a decrease in KChIP3 in the
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hippocampus of post mortem seizure patients (Hong 2003). These conflicting
pathologies indicate that localization and regulation of KChIP3 is highly
dependent on intracellular signaling pathways that intricately coordinate and
balance the function of KChIP3.

Role of KChIP3 in regulating NMDA receptor function

In the context of hyperexcitability and hippocampal-dependent deficits in
behavior, KChIP3 is a potentially important component of the balance between
excitation and inhibition. In addition to its role in promoting Kv4.2 expression and
function, KChIP3 also modulates glutamate receptor trafficking. KChIP3 interacts
with the GluN1 subunit of NMDA receptors to decrease surface expression and
NMDA-mediated current (Zhang et al 2010). Additional research also indicates
KChIP3 may interact with GluN2B as well, and may preferentially modulate
GluN2B-containing NMDA receptors (Zhang et al 2010; Wu et al 2010). This
interaction with GluN1 is calcium-dependent. The binding of each EF-hand
calcium sensor to a calcium ion results in a progressive reduction of current
(Zhang et al 2010; Wang and Wang 2012). Other studies in the calcium
insensitive overexpressing KChIP3 mice indicate that even in the absence of
calcium, KChIP3 can still inhibit NMDA receptors. However, this occurs through
interaction with the anchor protein PSD-95, and does not alter NMDA-mediated
current, but instead decreases surface expression (Wu et al 2010; Wang and
Wang 2012). As a result, KChIP3 can not only alter cellular function though the
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regulation of ion channels to dampen excitation, but also directly interact with
glutamate receptors to further decrease intracellular calcium levels and
glutamatergic receptor function.
KChIP3 may have an important role in ethanol-induced hyperexcitability in
the hippocampus. Its dual role in regulating both NMDA and Kv4.2 surface
expression and function creates the possibility that KChIP3 is part of a
homeostatic mechanism that balances local excitation and inhibition during
chronic ethanol exposure.

Activity-dependent translation in dendrites

Different proteins at glutamatergic synapses are important for the balance
of excitation and inhibition, and to maintain homeostasis during activitydependent alterations in the intra- and extracellular environment (Sutton et al
2006). Long-term maintenance of neuronal activity requires the induction of more
permanent mechanisms that induce transcription and translation of new protein
in dendrites and dendritic spines in an activity-dependent manner (Gardiol et al
1999; Kang and Schuman 2004; Holt and Bullock 2009; Zukin et al 2009; Dieck
et al 2014).
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Review of translation

In the brain, translation of new protein is a key step in synaptic plasticity and
in the processing and retention of required information (Cajigas et al 2010;
Darnell and Richter 2012; Holt and Schuman 2013). Typical activity-dependent
translational regulation is necessary not only to maintain proper synaptic function,
but also has important behavioral consequences (Sutton and Schuman 2006;
Costa-Mattioli et al 2009; Holt and Schuman 2013). Translation in dendrites and
dendritic spines, like axonal or somatic translation, is cap-dependent and relies
upon the unwinding of the 5’ cap for protein synthesis (Levy et al 1991; Steward
and Schuman 2001; Sutton and Schuman 2006). The process is divided into
three steps: initiation, elongation, and termination (Figure 1-2).
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Initiation is the most well characterized step in protein synthesis, and is also
the rate-limiting step for translation due to the number of components necessary
for the pre-initiation and initiation complexes (Nakamoto and Kalokfsky 1966;
Davis and Squire 1984; Holz et al 2005; Pestova et al 2007). This assembly
involves recruitment of eukaryotic initiation factors (eIFs) and coordinated activity
of different ribosomal subunits. After trafficking to the synapse, the eIF4E binds
the 5’ cap of the mRNA (Levy et al 1991; Pinkstaff et al 2001; Scheper and Proud
2002; Pestova et al 2007). Next, eIF4G acts a scaffolding protein for assembly of
the rest of the initiation complex (Oberer et al 2005; Hinnebusch and Lorsch
2012). The last initiation factor in this complex is eIF4A, which is the active
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helicase that unwinds structures in the 5’ untranslated region of the mRNA to
facilitate translation (Tsokas et al 2005; Sonenbergy and Dever 2003).
Collectively these three initiation factors eIF4E, -G, and -A along with eIF4H are
known as eIF4F once they are assembled into an active complex (Sonenberg
and Dever 2003; Oberer et al 2005; Hoeffer et al 2013). After assembly of eIF4F,
another initiation factor, eIF3 recruits the 40S small ribosomal subunit to the
assembled complex (Hinnebusch 2006). This subunit acts as a scaffold for
appropriate alignment and initial association of the tRNA with the other
components assembled for initiation (Colombo et al 1968; Erzberger et al 2014;
Korostelev 2014).
After assembly of the entire complex, the 40S subunit scans the
untranslated region as it unwinds until it reaches the start codon, AUG, which
codes for methionine (Colombo et al 1968; Revel et al 1968; Hussain et al 2014).
tRNA is responsible for bringing the appropriate amino acid to the polyribosome
based on the mRNA triplet base pairings. This methionyl- tRNA serves as a
specialized initiator for translation. GTP-bound eIF2 brings the methionyl-tRNA to
the 40S subunit (Clark and Marcker 1966; Revel et al 1968; Cheung et al 2007;
Erzberger et al 2014; Hussain et al 2014). Hydrolysis of GTP bound to eIF3 to
GDP signals for the dissociation of the small 40S subunit, which is replaced by
the large 60S ribosomal subunit (Holland et al 2004; Hinnebusch and Lorsch
2012; Gamalinda et al 2014).
Following initiation with the assembly of the necessary components and the
addition of the first amino acid, the rest of the mRNA is translated into protein
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through elongation. Elongation is a widely conserved process that is mediated by
eukaryotic elongation factors (eEFs) (Hinnebusch and Lorsch 2012; Sala 2014).
Like the final stage of initiation, this involves tRNAs bringing the appropriate
amino acid to the ribosome for addition on the translated protein (Dresios et al
2006). The elongation factor eEF1A in GTP-bound form separates the amino
acid from the tRNA. However, this process requires the GEF eEF1B to maintain
a certain rate of function for activity-dependent translation to occur (Rogers et al
2001; Kapp and Lorsch 2004; Cao et al 2014). After each amino acid addition,
the large 60S subunit slides down the mRNA via hydrolysis of the GTP bound to
eEF2 (Ryazanov and Davydova 1989; Kapp and Lorsch 2004; Heise et al 2014).
The final step in protein translation is termination. This step is not well
studied, and the components and the exact process are not completely
understood, compared to that of the two previous steps. However, like initiation
and elongation, termination also utilizes separate proteins that are eukaryotic
release factors (eRFs) for release of the finished peptide (Zhouravlev et al 1995;
Kapp and Lorsch 2004). Once the assembled polyribosome encounters the
consensus stop code, UAG, hydrolysis of GTP-bound to eRFs releases the
finished peptide and promotes disassembly of the current active complex to allow
the components to return to the pool of available subunits (Dever and Green
2012).
Most protein synthesis occurs in the soma, and the proteins are then
transported to different neuronal processes via molecular motors (Kanai et al
2004). However, more recent studies have followed lines of research focusing on
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the role of local dendritic protein synthesis and its relevance to synaptic plasticity,
particularly in the hippocampus (Kang and Schuman 1996; Asaki et al 2003;
Govindarajan et al 2011). While most of this production is somatic, dendritic
protein translation is necessary, in some circumstances, to maintain long-term
activity-dependent changes (Huber et al 2000; Martin et al 2000; Asaki et al
2003; Sutton and Schuman, 2006; Govindarajan et al 2011). Elimination of
dendritic translation through mutation of the mRNA dendritic targeting element
produced deficits in the spatial recognition and contextual learning (Kang and
Schuman 1996; Morris et al 2002; Sutton and Schuman; 2006). Typically, this
local translation involves a highly coordinated series of events with not only
mRNAs, but also assembly of the polyribosome for translation and intracellular
regulatory processes each component (Liu-Yesucevitz et al 2011; Parysan et al
2011; Korostelev 2014). Regulation of translation can occur at each of the three
stages.
Due to its function as the rate-limiting step and as the first point of contact
for mRNAs, the initiation step has several different components that alter both
the initiation and rate of translation at the polyribosome (Rogers et al 2001;
Dobrikov et al 2013). One of the most well-studied proteins involved in translation
is the cap-binding protein eIF4E (Raught and Gingras 1999; Rogers et al 2001;
Scheper and Proud 2002; Sonnenberg and Dever 2003; Gkogkas et al 2013;
Sonenberg and Hinnbusch 2009). This is the first protein to interact with mRNAs
and represents the first element in the rate-limiting step (Parysan et al 2013;.
Phosphorylation of eIF4E decreases the affinity for capped mRNA, which in turn,
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slows the rate of translation (Raught and Gingras 1999; Waskiewicz et al 1999).
This protein also interacts with 4 eukaryotic initiation-binding proteins (4E-BPs).
These regulate translation by binding to eIF4E and inhibiting interaction with the
5’ cap (Levy et al 1991; Rogers et al 2001). This includes 4E-BP2, nuclear FMRP
interacting protein (NuFIP) and cytoplasmic interacting proteins (Cyfips) that
convey long-term inhibition of total protein expression. These act as linker
proteins between the polyribosome and larger macromolecular complexes that
often include other proteins and noncoding RNAs to not only block the capbinding protein but to stall out the polyribosome to prevent cap-independent
translation (Bardoni et al 2003; Napoli et al 2008; Pathania et al 2014). Although
these act as translational repressors, they are important in the coordination of
activity-dependent protein synthesis. Knockout or dysfunction of these proteins
leads to aberrant synaptic plasticity, and deficits in hippocampal-dependent
learning tasks (Banko et al 2007; Liu-Yesucevitz and 2011; Santini et al 2012;
Pathania et al 2014). Activity of the alpha helicase is another component of
initiation that affects the rate of translation. The poly(A)-binding protein (PABP)
interacts with the 3’ end to circularize the mRNA (Le et al 2000; Atkins et al 2004;
Kahvejian et al 2005). This enhances unwinding of the helix and drastically
enhances the rate of translation (Atkins et al 2004; Dieck et al 2014).
The process of mRNA and protein elongation is regulated through
phosphorylation of elongation factors. Binding of GTP to eEF1A is relatively slow
without the GEF activity of eEF1B (Tsokas et al 2005; Cao et al 2014).
Phosphorylation of either of these elongation factors by PKC or casein kinase
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alters the rate at which elongation of the protein occurs (Price et al 1991;
Redpath and Proud 1993). Phosphorylation by PKC decreases the ability of
eEF1A to bind GTP and slows translation (Redpath and Proud 1993; Ryazanov
et al 1988; Tsokas et al 2005). However, phosphorylation of either protein by
casein kinase enhances the rate of translation (Price et al 1991). The larger
ribosomal subunit 60S slides down the mRNA and connects the appropriate
amino acids brought by the tRNA (Gamalinda et al 2014). This is controlled by
eEF2, which is subject to both acute and longer-term regulation (Ryazanov and
Davydova 1989). Acutely, calcium-activated eEF2 kinase (eEF2K) prevents
hydrolysis of GTP by eEF2, and inhibits movement of the larger subunit down the
mRNA (Ryazanov et al 1988). However, eEF2K is only activated by acute influx
of calcium at the synapse; inhibition lasts around 30 minutes following the influx
of calcium (Ryazanov and Davydova 1989; Sala 2014). Dephosphorylation of
eEF2 by PP2A occurs after activation of other intracellular signaling pathways
(Sonenberg and Dever 2003; Im et al 2009).
Although little is known about the process of termination of translation, this
is also regulated by phosphorylation of release factors that alter GTP hydrolysis
and the rate of release. However, more regulatory steps occur during the first two
steps, initiation and elongation, where mRNA stability, assembly of the complex,
and rate of synthesis are affected.
Another important component regulating translation does not necessarily
alter the rate of translation, but rather the mRNAs that are translated. mRNAbinding proteins are a large class of proteins that can form macromolecular
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complexes to regulate mRNA interaction with the polyribosome. These proteins
are important in trafficking, localization, and stability of mRNAs after transcription
(Zalfa et al 2006; Bramham and Wells 2007; Bolognani and Perrone-Bizzozero
2008). These proteins contain multiple binding regions for RNAs; however, each
region interacts with a specific mRNA sequence. This gives these proteins the
ability to bind to several different targets while also giving target specificity (Jones
2003; Shan et al 2003). They are often regulated by post-translational
modifications, with the three main types being phosphorylation, arginine
methylation, and small ubiquitin-like modification (SUMO) (Glisovic et al 2008).
These change activity and RNA binding affinities, induce the formation of
ribonucleoprotein complexes (RNP), and creates conformational changes that
alter mRNA binding and transport (Shan et al 2003; Darnell and Richter 2012;
Hinnebusch and Lorsch 2012). Many of these proteins, like fragile X mental
retardation protein (FMRP) are translational repressors that prevent interaction
with the ribosome (Laggerbauer et al 2001; Darnell et al 2011). However other
proteins such as the Staufen family of RNA-binding proteins, are important in
processed mRNA transport down microtubules and into dendrites (HeraudFarlow and Kiebler 2014). Other proteins, such as Smaug, are important in RNA
destabilization and degradation (Tadros et al 2007; Bologani and PerroneBizzozero 2008; Gotez and Wahle 2015. However, these proteins also form RNP
complexes that contain mRNAs and multiple mRNA-binding proteins to properly
regulate trafficking, localization, stability, and translation activity (Braham and
Wells 2007; Bologani and Perrone-Bizzozero 2008; Darnell and Richter 2012).
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NMDA receptors and dendritic translation

Translation of new protein is a finely tuned process with several regulatory
elements that alter not only assembly of the complex and mRNA binding, but
also the rate at which mRNAs are translated. In dendrites, the process of local
translation is an essential component of the maintenance of adaptive activitydependent changes to neuronal activity (Ostroff et al 2002; Costa-Mattioli et al
2009; Holt and Schuman 2013). NMDA receptors are a key component for
initiating activity-dependent translation, and NMDA-dependent processes, such
as NMDA-dependent LTP, require protein synthesis to occur (Marin et al 1997;
Im et al 2009; Costa-Mattioli et al 2009). These receptors activate different
downstream components that alter local translation in different ways, and
regulate all three stages of protein synthesis.
During initiation, several components of the initiation complex are subject to
activity-dependent regulation through phosphorylation of different kinases in
order adjust the rate of translation to the current cellular conditions. In vivo and in
vitro studies have outlined a role for NMDA-dependent ERK activation in altering
specific components of the initiation complex. Downstream substrates MAP
kinase signal interacting kinases (Mnk1 and Mnk2) phosphorylate the capbinding protein eIF4E (Raught and Gingras 1999; Perkinton et al 2002). This
phosphorylation enhances activity and the general rate of translation by pulling
mRNAs more quickly to the ribosome. Activation of ERK and Mnk kinases via
NMDA receptor activity and this subsequent increase in eIF4E activity promotes
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new protein synthesis to sustain late phase LTP in the mouse hippocampus
(Knauf et al 2001; Perkinton et al 2002; Carriere et al 2011). Mutation at the
eIF4E phosphorylation does not alter the induction of LTP, but hippocampal
neurons do not maintain LTP activity (Topisirovic et al 2004; Im et al 2009). As
previously mentioned, PI3-K is activated during the transition from early to late
phase LTP, and induces ERK-independent translational changes via the
mTORC1 pathway (Perkinton et al 2002; Shahbazian et al 2006). This regulatory
pathway alters several downstream components that are necessary to coordinate
activity-dependent translation.
During the elongation phase of translation, activation of NMDA receptors
continues to regulate the rate of protein synthesis. However, unlike initiation, this
regulation occurs during early phase LTP as well as late phase (Im et al 2009).
The eEF2 kinase eEF2K operates via a calcium-dependent mechanism that
facilitates binding to eEF2 to slow GTP hydrolysis and the rate of translation
(Browne and Proud 2004; Im et al 2009). This paradoxical coupling of both
inhibition and activation of translation at different stages represents a finely
regulated

process

that

facilitates

the

necessary

cellular

functions

to

accommodate the different requirements of both early and late phase LTP (Im et
al 2009). Although NMDA receptor activation enhances the initiation process, it
inhibits elements that are downstream to slow translation. However, this inhibition
is transient and spatially restricted (Ryazanov and Davydova 1989; Martin et al
2000; Govindarajan et al 2011). Persistent activation of NMDA receptors
produces transient blockade of translation via eEF2 inhibition, despite the
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presence of calcium at the synapse (Marin et al 1997; Browne and Proud 2004;
Im et al 2009). Additionally, eEF2K phosphorylation is restricted to the activated
synapses and does not alter translation outside of dendritic spines (Ryazanov
and Davydova 1989).
This initial repression of translation may coordinate LTP in different ways. It
may serve as a mechanism to allow coordinated mRNA transport and synaptic
arrangement to produce the necessary protein needed to maintain LTP (CostaMattioli et al 2009; Sossin and Lacaille 2010; Thomas et al 2013; Bailey et al
2015). This may allow for mRNA-specific inhibition of translation, rather than a
blanket, general blockade of all translational mechanisms (Doench and Sharp
2004; Bramham and Wells 2007, Dieck et al 2014). At the same time, general
protein translation is repressed following NMDA receptor activity, and the
expression of certain locally translated proteins, such as CaMKII, are increased
(Pinkstaff et al 2001; Asaki et al 2003; Costa-Mattioli et al 2009).
NMDA-dependent LTP is characterized by not only alterations in synaptic
activity, but also the production of new protein (Kapp and Lorsch 2004; Klann
and Richet 2007; Kim et al 2013). As such, studies have confirmed that NMDA
receptor activity is important in the regulation and coordination of activitydependent translational mechanisms. This process involves several components
of the translation machinery that both promote and inhibit local activity-dependent
translation (Klann and Richet 2007). With defined deficits in NMDA-dependent
LTP in the hippocampus resulting from chronic ethanol exposure, translational
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mediators and components controlling the rate of translation are likely candidate
proteins for homeostatic regulation in CIE.

mTORC1 translational pathway

Local regulation of dendritic translation requires the convergence and
coordination of several different proteins to allow for fluid, effective activitydependent translation. However, many of these components, those that both
promote and inhibit translation, are part of a common regulatory pathway. In
dendrites and dendritic spines, one of the most well characterized pathways
regulating activity-dependent translation is the Akt-mTORC1 pathway (Brown et
al 1995; Gingras et al 2001; Dibble and Cantley 2015). This is a large, diverse
pathway with downstream components that control dendritic and somatic
translation, and both promote and inhibit protein translation through activation of
different substrates (Figure 1-3) (Browne and Proud 2003; Holz et al 2005).
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Phosphorylation of phosphoinositide 3-kinase (PI3-K) initiates activity of
protein kinase B (Akt). In turn, Akt phosphorylates the 2164 threonine residue to
induce assembly mTORC1. Active mTORC1 involves the addition of the catalytic
subunit Raptor to the complex (Kim et al 2002; Dibble and Cantley 2015).
Following raptor assembly into the complex, the p70 ribosomal protein S6 kinase
1 (S6K1) is phosphorylated (Brown et al 1995; Kim et al 2002). Like mTORC1,
S6K1 has a myriad of downstream proteins that control translation in the soma,
axons, dendrites, and dendritic spines that both promote and inhibit activitydependent translation, depending on the localization and function in the neuron
(Burnett et al 1998; Gingras et al 2001; Holz et al 2005; Im et al 2009; Ma and
Blenis 2009). Some of these substrates include the cap-binding protein eIF4E,
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the alpha-helicase eIF4A, and the ribosomal subunit S6; these are all
components of the active polyribosome that are necessary for translation (Hara
et al 1997; Hara et al 1998; Gingras et al 2001; Ma and Blenis 2009). However,
S6K1 also activates other substrates including mRNA-binding proteins like FMRP,
that serve as a translational repressors, Smaug, which facilitates mRNA
degradation, and Cyfip1, which is a 4E-BP that halts all mRNA association with
the polyribosome (Burnett et al 1998; Czaplinski and Singer 2006; Ma and Blenis
2009; Chen and Joseph 2015). Activation of these downstream components
follows discrete regulatory mechanisms that tailor activation of each component
to the particular change in activity to compensate in both a short- and long-term
fashion (Holz et al 2005; Ma and Blenis 2009). Not all downstream proteins are
activated simultaneously or even phosphorylated at all during mTORC1 or S6K1
activation (Holz et al 2005).
mTORC1 activity is regulated through a number of different mechanisms,
and controls a number of activity-dependent cellular functions in addition to
translation including cell growth and apoptosis. In addition to mTORC1, Akt also
activates mTORC2 (Urbanska et al 2012). These two complexes differ in their
assembly, activity, and sensitivity to rapamycin. mTORC1 is composed of the
mTOR and mTOR-associated protein (Ma and Blenis 2009). The recruitment of
the catalytic subunit Raptor activates the complex to phosphorylate downstream
substrates (Ma and Blenis 2009; Urbanska et al 2012). While dephosphorylation
causes dissociation of this subunit and ceases activity; exactly how it
differentially regulates activity of each of its downstream substrates is not known.
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NMDA-dependent regulation of mTORC1

In addition to ERK/Mnk regulation of translation, NMDA receptor activity
also regulates mTORC1 activity to control local translation. In this context, it
triggers the translation of mTORC1 substrates including p70 ribosomal S6
kinases 1 and 2 as well as p90 ribosomal S6 kinases 1 and 2 (Rsk1 and 2)(Lenz
and Avruch 2005; Gong et al 2006; Carriere et al 2011). This is completely
independent of ERK activity and is blocked by treatment with rapamycin (Carriere
et al 2011; Dibble and Cantley 2015). Additionally, activation of other
downstream mTORC1 substrates can regulate initiation and elongation. eIF4E
and other components of the initiation complex are regulated in an mTORC1dependent manner (Hara et al 1997; Hara et al 1998; Gingas et al 2001;
Shahbazian et al 2006). This alteration in activity of mTORC1 substrates
corresponds to an increase in S6K1 phosphorylation and activity (Hara et al
1998; Holz et al 2009; Fenton et al 2011). Other studies also suggest the nature
of mTORC1 activity in NMDA-dependent regulation of translation (Marin et al
1997; Lenz and Avruch 2005; Gong et al 2006; Meng et al 2013). Stimulation of
NMDA receptors and subsequent activation of mTORC1 and S6K1 leads to the
suppression of specific substrates that are key in balancing dendritic excitation,
such as Kv1.1 (Raab-Graham et al 2006; Meng et al 2013). Treatment with
rapamycin abolished this NMDA-induced decrease in Kv1.1. Additionally,
treatment with rapamycin abolishes late-, but not early-phase LTP in the
hippocampus, suggesting that its activation is key for synthesis of new that are
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necessary to maintain but not intiate LTP (Raab-Graham et al 2006; Bekinschtein
et al 2007; Russo et al 2013). In the context of ethanol-seeking behaviors,
mTORC1 activation is necessary for the reduction in ethanol-seeking behaviors
in rats treated with the NMDA receptor antagonist, ketamine (Sabino et al 2013).

mTORC1 in dendritic spines and its role in behavior

The role of mTORC1 as a translational regulatory pathway is well studied.
However, long-term differences or dysfunction of dendritic translation is
associated with differences in dendritic spine density and morphology (Hoeffer et
al 2012; Bowling and Klann 2014; Tang and Sulzer 2014). In animal models of
autism spectrum disorders, hyperactive mTORC1 is correlated with aberrant
spine morphology compared to controls (Huber et al 2002; Bowling and Klann
2014). However, the connection between mTORC1-mediated translation and
actin polymerization and spine formation is not well characterized, but there are
studies showing correlations between alterations in mTORC1 activity and
alterations in dendritic spines (Hoeffer et al 2012; Tang and Sulzer 2014).
Neurodegenerative disorders that exhibit decreases in mTORC1 activity also
show deficits with activity-dependent maintenance of actin polymerization and
differences in spine formation (Urbanska et al 2012; Takei and Hiroyki 2014;
Tang and Sulzer 2014)
Due to its well-characterized role in protein translation, mTORC1 is also
studied in behaviors that have previously been shown to rely on LTP. Inhibition of
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mTORC1 via treatment with rapamycin in the dorsal hippocampus prevented
consolidation and reconsolidation of contextual fear conditioning (Bekinschtein et
al 2007). Inhibitory avoidance tasks significantly increased mTORC1 and S6K1
phosphorylation and activity. Inhibition of mTORC1 prevented this increase in
S6K1 phosphorylation and hippocampal-dependent learning (Im et al 2009;
Fenton et al 2011).
Previous studies have shown that long-term exposure to ethanol
preferentially up or down regulates specific proteins at glutamatergic synapses.
In particular, proteins necessary for NMDA receptor signaling, such as CaMKII
and PSD-95, are upregulated (Barak et al 2013; Sabino et al 2013). Additional
components of the mTORC1 pathway that are key for appropriate, proficient
activity-dependent translation, such as 4E-BP1 and S6K1, exhibit enhanced
activity following chronic self-administration of ethanol (Nesta et al 2010; Barak et
al 2013). Treatment with rapamycin not only inhibited these cellular changes in
protein expression, it also prevents reinstatement of ethanol-seeking behaviors
during cue-induced reinstatement. This inhibition of reinstatement was present
after two weeks of rapamycin treatment (Barak et al 2013).
Included in the mTORC1 pathway are downstream components of S6K1
that serve as mRNA-binding proteins (Zalfa et al 2006; Chen and Joseph 2015).
As previously discussed, these proteins, although translational repressors, are
essential components for coordinated translation. Of these, the translational
repressor fragile X mental retardation protein (FMRP) has previously been shown
to have a key role in regulating de novo protein synthesis in response to changes
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in activity at glutamatergic synapses (Zalfa et al 2006; Darnell et al 2011; Henry
et al 2011; Darnell and Klann 2013; Fernandez and Bagni 2013).

Role of FMRP in activity-dependent translation

FMRP in dendritic translation

The mRNA-binding protein FMRP is of particular importance in the
regulation of local translation in dendrites and dendritic spines (Bardoni et al
2001; Darnell et al 2011; Zalfa et al 2006). FMRP is a translational repressor that
binds to mRNAs and prevents mRNA interaction with the cap-binding protein
eIF4E (Laggerbauer et al 2001; Fernandez and Bagni 2013; Sala et al 2014). It is
one of the necessary components for activity-dependent translation in dendrites
in the hippocampus and is also needed to maintain homeostatic basal protein
levels (Bardoni et al 1997; Henry 2011; Fernandez and Bagni 2013). It has been
most well studied in the context of neuronal development and fragile X syndrome,
and there are fewer studies investigating the role of FMRP in typical activitydependent neuronal function (Sutherland 1979; Weiler et al 2004; Henry 2011;
Schaeffer et al 2012). FMRP is encoded by the fmr1 gene that is highly
conserved throughout the animal kingdom, from drosophila to human (Bardoni et
al 1997; Laggerbauer et al 2001; Usdin and Kumari et al 2015). It codes for
seven different isoforms of FMRP, with isoform 6 being the most commonly
expressed. However, it is of note that each isoform varies in the mRNA binding

47

regions and potential differences in mRNA binding and activity have not been
characterized (Usdin and Kumari et al 2015).
Structurally, FMRP contains several binding regions for both coding and
noncoding RNAs as well as proteins that regulate the function of FMRP and
residues that undergo post-translational modification to mediate FMRP activity
(Schaeffer et al 2012; Adams-Cioaba et al 2010). For regulation of mRNA
translation, FMRP contains two KH domains as well as an RGG rich segment
(Figure 1-4) (Bardoni et al 1997; Adams-Cioaba et al 2010; Chen and Joseph
2015; Usdin and Kumari 2015). These regions contain ubiquitous sequences that
allow FMRP to interact with 3-4% of total mRNAs in hippocampal pyramidal
neurons (Jones 2003; Darnell et al 2012). These include proteins that modulate
the balance of excitation and inhibition such as Kv4.2, KChIP3, and the NMDA
receptor subunits (Darnell et al 2011, Gross et al 2011; Jan et al 2011; Lee et al
2011). However, each mRNA binding region tends to interact with specific
sequences on mRNAs. This allows FMRP to have specificity for specific mRNAs
while multiple regions maximizes binding partners (Brown et al 1995; Bardoni et
al 1997; Jones 2003; Darnell et al 2011; Schaeffer et al 2012). FMRP activity is
mediated by phosphorylation at three different serine residues, S496, S499, and
S503, located in the RGG-rich region (Bardoni et al 1997, Ceman et al 2003;
Edbauer et al 2010). Of interest in the context of mRNA activity is S499 (Bartley
et al 2014). This is a highly conserved site for post-translational modification that
alters FMRP’s mRNA binding activity (Jones et al 2001; Bhattacharya et al 2012;
Bartley et al 2014). Increases in phosphorylation at S499 via S6K1 increases
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FMRP activity (Ceman et al 2003; Holz et al 2005; Fenton and Grant 2011;
Bhattacharya et al 2012; Bartley et al 2014). This increase in activity causes an
increase in mRNA-FMRP interaction and therefore a decrease in protein
synthesis of that mRNA (Laggerbauer et al 2001; Ceman et al 2003; Darnell and
Klann 2013; Usdin and Kumari 2015).
FMRP also interacts with various proteins, noncoding RNAs, and miRNAs
that regulate its function. Two proteins, nuclear FMRP interacting protein (Nufip)
and cytoplasmic FMRP interacting protein 1 (Cyfip1), bind with FMRP to serve as
linker proteins of larger macromolecular complexes that may not only regulate
translation, but also mRNA localization and stability (Bardoni et al 2003; Napoli et
al 2008; Pathania et al 2014). In dendrites, Cyfip1 interacts with FMRP at sites
adjacent to the mRNA-binding KH regions. Once bound to FMRP, Cyfip1 also
interacts with the eIF4E to prevent all translation at that ribosome (Napoli et al
2008). This binding with the polyribosome may also serve to regulate the
translation of specific mRNAs. As seen in Figure 1-4, FMRP has different
binding regions for mRNAs and Cyfip1, and may interact with both Cyfip1 and
mRNA simultaneously (Zalfa et al 2006; Fernandez and Bagni 2013; Usban and
Kumari 2015). If so, the interaction of Cyfip1 and FMRP with the ribosome may
also serve to coordinate translation by holding certain mRNAs near ribosomes for
quick de novo protein synthesis (Zalfa et al 2006; Napoli et al 2008). FMRP also
binds noncoding RNAs, such as BC1 that interact with the ribosome to inhibit
translation (Zalfa et al 2003; Napoli et al 2008).
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In addition to translation, FMRP may also regulate RNA trafficking at the
synapse. Increases in phosphorylation at S503 increases FMRP binding to Dicerprocessed miRNAs (Ceman et al 2003; Jin et al 2004). Dicer cuts pre-miRNAs
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into shorter strands for insertion into the RNA-induced silencing complex (RISC)
(Hayashi-Takagi et al 2010). In this capacity, FMRP aids Dicer by interacting with
processed miRNAs through one of the KH domains and acts as an acceptor
protein to localize and traffic the miRNA to the other RISC components (Jin et al
2004; Zalfa et al 2006; Hayashi-Tagaki et al 2010). Outside of this capacity, there
is some controversy as to whether FMRP alters trafficking of mRNAs or holds
them at specific synapses in the dendrite. Studies from different groups have
produced contradictory results. In fmr1-/- mice, two different studies in the same
preparation have reported opposite results for the same mRNA. One study
implicated FMRP in Kv4.2 mRNA trafficking (Gross et al 2011). However,
another study examining the FMRP-mRNA binding domains showed that
mutation of the binding site on either FMRP or Kv4.2 mRNA did not produce any
alteration in mRNA trafficking down the dendrite (Lee et al 2011). However, it
was postulated that mRNAs may still be trafficked down the dendrites, but
without FMRP interaction these mRNAs are unstable (Gross et al 2011).

FMRP and synaptic plasticity

As an mRNA-binding protein, FMRP has numerous targets of interest
related to maintenance of homeostasis and glutamatergic signaling. These
include PSD-95, CaMKII, Arc, Kv4.2, KChIP3, and NMDA receptor subunits
(Brown et al 1995; Muddashetty et al 2007; Jones et al 2012; Niere et al 2012;
Darnell et al 2013). FMRP is also implicated in regulation of specific mRNAs that
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are translated with relatively low efficiency. These are 5’- TOP mRNAs, which are
mRNAs that contain an unusual terminal oligopyramidine tract at the 5’
untranslated region (Levy et al 1991; Jefferies et al 1997). Most of the proteins
directly involved in the assembly of the initiation and translation complexes, as
well as several proteins necessary for regulation of ribosome assembly, are TOP
mRNAs (Levy et al 1991; Brown et al 1995; Zalfa et al 2006). These mRNAs are
transcripted, transported down into neuronal processes where they are
sequestered in inactive ribonucleoprotein complexes (Bardoni et al 2003; Antar
et al 2005; Zalfa et al 2006). The association of these proteins with active
polyribosomes is significantly lower than other proteins whose mRNAs are
trafficked out to the synapse under basal conditions (Levy et al 2991; Jefferies et
al 1997). Typically, in non-neuronal cell types, activation of these mRNAs
involves trafficking back to active translation sites in response to growth factor
stimulation (Bardoni et al 2003; Castets et al 2005). However, in mature neurons,
this also occurs in response to activity-dependent changes in synaptic plasticity.
Another aspect of these mRNAs that is very different from other transcripts is that
these mRNAs have an almost ‘all or none’ translational efficiency (Levy et al
1991; Aloni et al 1992; Jefferies et al 1997). Under basal state conditions,
practically none of these mRNAs are translated, but, after synaptic stimulation,
the overwhelming majority of the mRNAs present near active synapse are
trafficked to active polyribosomes for translation. Due to this sudden shift in
translation, FMRP may play a significant role in tethering these proteins near
active polyribosomes in dendrites and dendritic spines to stabilize the mRNA
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transcript and promote immediate translation as needed (Levy et al 1991; Aloni
et al 1992). Translation of these mRNAs is also almost exclusively dependent on
mTORC1/S6K1 activation. Treatment with rapamycin almost completely ablates
de novo protein synthesis of these mRNAs, even with strong synaptic stimulation
or growth factors (Jefferies et al 1997). Since these TOP mRNAs are transcripts
of necessary components in all three stages of translation, such as eIF4E, eIF4A,
eEF2, and eRF2, dysregulation of translation of these mRNAs directly alters the
ability to the facilitate protein translation and maintain changes in synaptic
plasticity, such as LTP (Levy et al 1991; Brown et al 1995; Schaeffer et al 2012).
FMRP is a key mediator of activity-dependent translation of numerous
mRNAs in dendrites and dendritic spines (Ramocki and Zoghbi 2008). These
mRNAs include several that code for proteins that are essential in mediating
synaptic excitability (Brown et al 1995; Jones 2003; Darnell et al 2013). In
disorders characterized by hyperexcitability, such as fragile X syndrome and
epilepsy, dysfunctional FMRP creates an aberrant basal state and dysregulated
activity-dependent translation (Krueger and Bear 2011; Vislay et al 2012). Fragile
X syndrome is characterized by the expansion of the regulatory CpG region that
recruits transcriptional regulators that promote hypermethylation and silencing of
the gene (Bardoni et al 1997; Usdin and Kumari 2015). Therefore, many
individuals with fragile X syndrome completely lack FMRP (Sutherland 1979;
Laggerbauer et al 2001). This lack of FMRP leads to increases in basal state
protein levels, including Kv4.2 and KChIP3 (Brown et al 1995; Darnell et al 2011;
Gross et al 2011; Schaeffer et al 2012). In individuals with fragile X syndrome
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and in fmr1-/- mice, synaptic plasticity is limited and while induction of activitydependent mechanism is unaffected, these processes cannot be maintained.
Although FMRP is a translational repressor, it has an important role in
coordinating and fine-tuning mRNA interactions to produce the necessary
increases in protein expression to maintain activity-dependent processes, such
as LTP or LTD (Ostroff et al 2002; Niere et al 2012; Maurin et al 2014). Complete
lack of FMRP has greater effects on LTD compared to LTP, but this effect may
be age-dependent, vary by brain region, and depend on the knockout mouse
model (Eadie et al 2010; Niere et al 2012). In the nucleus accumbens, adult
fmr1-/- mice display impaired NMDA-dependent plasticity (Neuhofer et al 2015).
Additionally, in more recent mouse models of fragile X, NMDA-dependent LTP is
also impaired in the hippocampus (Mittman 2009; Eadie et al 2010)
FMRP may also control excitability by altering the polyribosome itself. As a
regulator of 5’ TOP mRNAs, FMRP activity alters protein expression of the
obligatory subunits for active ribosomes (Levy et al 1991). Lack of FMRP in
animal models has shown deficiencies in activity-dependent translation of these
proteins. Although basal protein expression levels remain unchanged compared
to control animals, these mRNAs are trafficked to the ribosome with low
efficiency during activity-dependent synaptic plasticity, despite relatively normal
levels of other mRNA- binding proteins (Levy et al 1991; Jefferies et al 1992).
This suggests that FMRP not only regulates proteins that directly mediate
synaptic function, but also those necessary for maintenance of synaptic plasticity.
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Studies evaluating protein translation during epileptigenesis show that,
although there is no change in total protein expression of FMRP, there is
aberrant regulation of FMRP activity. Proteins that balance local glutamatergic
inputs, such as Kv4.2 and KChIP3, are downregulated in both clinical patients
and mouse models of temporal lobe epilepsy (Muddashetty et al 2007; Lee et al
2011; Fernandez and Bagni 2013; Maurin et al 2014). In some of these mouse
models, FMRP total protein expression remains unaffected, but trafficking and
FMRP-mRNA interactions are altered compared to controls, indicating a role for
FMRP in activity-dependent protein translation in epilepsy (Mittman 2009; Lee et
al 2011; Neuhofer et al 2015).
Due to its previously described role in regulating basal protein levels and
activity-dependent translation of proteins altered by chronic ethanol exposure,
FMRP is a likely candidate for mediating ethanol-induced hyperexcitability in the
hippocampus. Blockade of upstream components of FMRP prevent the ethanolinduced alterations in protein expression. In other pathologies characterized by
hyperexcitability, these alterations in protein expression and upstream kinases
correspond to alterations in FMRP expression and activity.

FMRP and actin dynamics

Alterations in protein expression are often accompanied by changes in actin
polymerization and spine morphology. Patients with fragile X syndrome who lack
FMRP, have increased density of immature stubby dendritic spines and a
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significant decrease in long/thin spines (Hoeffer et al 2012). In drosophila, FMRP
interacts with a Cyfip protein that is a regulator of actin polymerization and
synapse development (Schenck et al 2003; Henry 2011; Zhao et al 2013). In
rodent models, fmr1-/- also display impaired spine development (Dictenberg et al
2008; Henry 2011). Conversely, Cyfip+/- mice show a behavioral phenotype
characterized by deficits in hippocampal-dependent learning and increases in
basal protein expression, similar to fmr1-/- mice (Antar et al 2003; Pathania et al
2014; Han et 2015). However, this connection between spine development and
protein translation has not been well characterized. Cyfip proteins provide a
potential link to activity-dependent actin polymerization and translational changes
associated with synaptic plasticity (Lee and Jan 2012).

Spine morphology and activity-dependent translation

Overview of actin dynamics

Regulation of actin dynamics and morphology of dendritic spines involves a
coordinated, highly regulated activity-dependent mechanism that balances the
acting polymerization with functional changes at the synapse.
Actin cytoskeletal dynamics are essential to maintain proper neuronal
function. One particular regulatory element is the WAVE complex. The WASPfamily veropolin homologous protein (WAVE) is found in nearly all cells, including
neurons, and is active in a number of different cellular processes (Bompard
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2004; Stradal et al 2004; Kim et al 2006; Pollitt and Insall 2009). The WAVE
complex consists of WAVE1, Arp2/3, Hem1, Abi1, and either Cyfip1 or 2. While
the complex is inactive when completely assembled, dissociation of Cyfip/Hem1
allows for its activation via Arp2/3 nucleation of actin filaments. When assembled
into the WAVE complex, Cyfip blocks the Arp2/3 activating domain (VCA region)
and prevents activity-dependent actin polymerization. In order to facilitate actin
polymerization, Arp2/3 must have a free VCA region and be activated by an Factin filament (Smith and Rong 2004; Stradal et al 2004; Kim et al 2006).
Arp2/3-mediated polymerization of G-actin to F-actin filaments is a four step
process. The first step is dissociation of the Cyfip/Hem1 inhibitory complex,
which exposes the VCA region (Kim et al 2006; Pollitt and Insall 2009). The next
step requires the uninhibited Arp2/3 protein to bind to a preformed actin filament.
Following filament binding, Arp2/3 tethers a free actin monomer to the existing
filament. The final step is elongation of the actin chain with the addition of other
actin monomers. Initiation of this process of actin polymerization is ATPdependent (Suetsugu et al 1999; Innocenti et al 2004; Kim et al 2006). Hydrolysis
of ATP bound to Arp2 serves as a timing mechanism to promote dynamic actin
networks that can easily and readily respond quickly to activity-dependent
changes. ATP hydrolysis is stimulated by interaction with either the actin
monomer or filament (Smith and Rong 2004; Innocenti et al 2004). Therefore,
hydrolysis may occur before the polymerization step is complete. However, the
rate of nucleation of actin monomers matches the rate of ATP hydrolysis.
Phosphate dissociation does not immediately induce disassembly of the F-actin,
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but does allow for factors such as cofilin that facilitate the breakdown of
filamenteous actin into actin monomers to interact with the newly formed chain
(Kasai et al 2003; Okamoto et al 2007; Pilpel and Segal 2005; Bellot et al 2014).

The role of Cyfip in activity-dependent spine changes

Dissociation of Cyfip from the WAVE complex is the first step that is
necessary for WAVE activation and subsequently actin polymerization (Kim et al
2006; Bellot et al 2014). Previous studies have shown a role for Rac1 signaling in
regulating WAVE-mediated actin polymerization. However, Rac1 does not
directly interact with the WAVE complex (Miki et al 1998; Rao and Craig 2000;
Tolias et al 2005). More recent studies have shown that Rac1 interacts with Cyfip
to facilitate dissociation and disinhibition of the VCA region (Figure 1-5). GTPbound Rac1 induces Cyfip/Hem1 to dissociate from the rest of the WAVE
complex (Miki et al 1998: Tolias et al 2005; Bongmba et al 2011). This
dissociation relieves the Cyfip-mediated block on the VCA region of Arp2/3
(Machesky et al 1999; Eden et al 2002; Choi Et al 2005). Following this
disinhibition, Arp2/3 can polymerize actin monomers to filamentous actin, and
hydrolysis of GTP allows for Cyfip to reassociate with WAVE and prevent further
cytoskeletal remodeling via WAVE. The binding of GTP Rac1 requires GEF
activity. However, it is unclear which GEF is involved in this process, and how it
is regulated. Unlike many Rac1-mediated processes, this is independent of Rho
A activity and it is not affected by Cdc4 activation (Suetsugu et al 1999; Eden et
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al 2002; Tolias et al 2005). Regulation of spine morphology and actin dynamics
may have significant functional implications. Decreases in protein translation are
associated with immature spine development and impairment of synaptic
plasticity. This difference in spine morphology may have a contribution to the
synaptic compartmentalization and the development or maintenance of LTP
(Dahl et al 2003; Soderling et al 2003; Maurin et al 2014).
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As mentioned above, the inactive WAVE complex contains either Cyfip1 or
2. These two proteins, although 88% homologous, are encoded by different
genes, and have a key role in dendritic translation and actin dynamics (Antar et
al 2003; Billuart et al 2003; Schenck et al 2003; Abebkhouhk and Bardoni 2014).
Yeast-two hybrid studies show both Cyfip proteins were found to interact with
FMRP (Napoli et al 2008). However, in vivo studies have shown preferential
interaction of Cyfip1 with FMRP over Cyfip2 (Antar et al 2003). Cyfip2 was found
60

to localize to the WAVE complex and alter actin polymerization over protein
translation (Antar et al 2003; Bongmba et al 2011; Abekhoukh et al 2014).
Clinical studies show that aberrant function of both proteins may produce similar
phenotypes. Unregulated Cyfip1 mRNA is present in some patients with autism
spectrum disorders, which is often a comorbid diagnosis with fragile X syndrome
(Sutherland 1979; Turner et al 1980; Hoeffer et al 2012). Additionally, some
clinical populations with autism spectrum disorder or fragile X syndrome also
have increased Cyfip2 mRNA and protein expression (Hoeffer et al 2012). This
suggests that protein translation and actin dynamics may be connected, and that
alterations in either process produces a similar pathology.
Alterations in actin dynamics and spine morphology occur as a result of
activity-dependent changes at glutamatergic synapses. However, like protein
translation, changes in spine morphology involves a highly coordinated pathway
with several components that regulate actin polymerization. As a key regulator of
the WAVE complex, Cyfip2 was recently found to have a role in drug-induced
alterations in spine morphology. Kumar et al found a naturally occurring
polymorphism between two lines of commercially available C57BL/6 animals.
This polymorphism did not alter total Cyfip2 expression, rather it changed the
stability of the protein. In the C57BL/6N animals, Cyfip2 showed a decreased
half-life compared to C57BL/6J mice. This created a higher turnover in protein,
and these animals also showed decreased spine density in the nucleus
accumbens. This decrease in density was due to a decrease in both mature
long/thin spines, and immature stubby spines. Additionally, these 6N did not
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show the typical behavioral responses to acute or chronic cocaine administration.
Passive injection of cocaine did not elicit the increase in locomotor activity in 6N
animals that was seen with 6J mice. 6N mice were also resistant to reinstatement
following a cocaine prime. This is likely due to the Cyfip2 polymorphism, as
experiments using a knockin on a C57BL/6J background produced the same
results (Kumar et al 2013).
Atlerations in spine morphology may have a direct or indirect role in
modulating protein translation and cellular function. Translation and actin
dynamics might represent a coupled mechanism that must occur in tandem to
have functional changes in synaptic plasticity.

Summary

Ethanol affects many areas of the brain including reward circuitry and
memory systems, which include the hippocampus. While acute exposure to
ethanol dampens excitation while promoting inhibition, chronic ethanol exposure
induces activity-dependent changes to accommodate the persistent decrease in
excitation (Carpenter-Hyland and Chandler 2006; Zhou et al 2007; Enoch et al
2012; Zorumski et al 2014). In dendrites and dendritic spines, this is
characterized by an increase in excitation and a decrease in local inhibition.
However, the mechanisms driving these changes are not fully understood.
It has previously been shown that chronic ethanol increases NMDA receptor
activity and expression. But, regulation of excitatory inputs in dendritic spines
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also includes proteins that mediate inhibition. Of the proteins regulating excitation
in dendrites and dendritic spines, Kv4.2 and its auxiliary protein KChIP3 are
viable candidates for ethanol-induced homeostatic changes in inhibition. Kv4.2 is
an A-type K+- channel that is one of the main regulators of backpropagating
action potentials and excitotoxicity (Kim et al 2007; Kaufmann et al 2012; Labno
et al 2014). Other disorders characterized by hyperexcitability show decreases in
Kv4.2 expression and function (Hong et al 2003; Monaghan et al 2008; Aronica
et al 2009). Additionally its interacting protein KChIP3 not only enhances
inhibition by promoting Kv4.2 surface expression and function, but also inhibits
NMDA-mediated current and protein expression (Kunjilwar et al 2004; Lin et al
2004; Norris et al 2010; Zhang et al 2010; Wang et al 2012). These proteins
exhibit inverse activity-dependent changes in expression and function. As NMDA
receptors are activated, Kv4.2 expression decreases. Taken together, Kv4.2 and
KChIP3 may have an influential role in mediating the homeostatic changes
induced by neurons in the hippocampus to balance increased NMDA receptor
expression and function.
Previous studies have shown hippocampal-dependent behaviors rely on the
synaptic mechanism of LTP to execute learned behaviors that involve long-term
memory, and this process may be altered by chronic ethanol exposure.
Maintenance of LTP requires the induction of de novo protein synthesis in
dendrites and dendritic spines (Pastalkova et al 2006; Govindarajan et al 2011;
Hill et al 2013). The process of new protein synthesis relies on coordinated
activity to increase or decrease expression of specific proteins. The factors in
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dendrites and dendritic spines that mediate this activity-dependent translation
have not been identified, they are components of the mTORC1 pathway and its
downstream substrate FMRP is a likely candidate protein (Ma and Bliss 2009;
Hoeffer 2012; Nesta 2014). As an mRNA-binding translational repressor, FMRP
interacts with several mRNAs whose proteins are altered following chronic
ethanol exposure, as well as the proteins of interest including Kv4.2, KChIP3,
and NMDA receptor subunits (Jones 2003; Darnell et al 2012; Schaeffer et al
2012). FMRP is also one of the key proteins mediating activity-dependent
changes in protein homeostasis and is necessary for maintenance of basal
protein levels (Antar et al 2005; Zalfa et al 2006; Henry 2011; Darnell and Richter
2012). However, the role FMRP may have in regulating specific mRNAs during
chronic ethanol exposure is completely uncharacterized. Studies in this
dissertation seek to determine whether FMRP expression or activity is altered
following chronic exposure, and if these changes correspond to alterations in
FMRP-mRNA binding.
Long-term changes in protein expression at glutamatergic synapses is also
accompanied by changes in dendritic spines. Disorders with disrupted
translational regulation, such as fragile X syndrome show aberrant spine
distribution and morphology (Jones 2003; Antar et al 2005; Castets et al 2005;
Dictenberg et al 2008; Han et al 2015). It is not clear how these two processes
are connected and how ethanol may alter both to maintain neuronal homeostasis.
Cyfip2 is not only an interacting protein of FMRP, but also is necessary for
appropriate actin polymerization (Pilpel and Segal 2005; Kim et al 2006; Chen et
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al 2014). As seen with translational deficits, dysfunction of Cyfip2 induces
alterations in protein translation, and these alterations correspond to resistance
in developing drinking behaviors (Nesta et al 2012; Barak et al 2013; Han et al
2015). Therefore, the question remains: how does chronic ethanol facilitate
activity-dependent homeostatic changes in dendrites and dendritic spines? The
overarching hypothesis of this dissertation is that FMRP is necessary for
activity-dependent homeostatic changes in protein expression and spine
morphology following chronic ethanol exposure (Figure 1-6)

Specific Aims

Specific Aim 1: Test the hypothesis that exposure to chronic ethanol alters
downstream substrates of FMRP at dendritic spines. As key regulators of
excitability and plasticity, Kv4.2, KChIP3, and NMDA receptor subunits are likely
targets for homeostatic changes in protein expression to reestablish balanced
neuronal signaling. These proteins are also downstream targets of FMRP, one of
the main mediators of activity-dependent translation in dendrites and dendritic
spines in the hippocampus. Studies under this aim will establish the nature of
activity-dependent homeostatic alterations in protein expression following chronic
ethanol exposure, and examine how ethanol may alter FMRP expression and
function to drive these changes.
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Specific

Aim

2:

Test

the

hypothesis

that

inhibition

of

FMRP

phosphorylation prevents ethanol-induced translational changes in the
hippocampus. Although ethanol may alter FMRP activity through changes in
phosphorylation, total protein expression, or binding partners, it may not be an
essential component of ethanol-induced homeostasis. As a potential major
regulatory element in the translational mechanism of ethanol-induced changes, it
is necessary to determine the nature of FMRP-mediated changes in the
hippocampus during chronic ethanol exposure. The hypothesis tested under this
aim is whether blockade of FMRP activity alter ethanol-induced, homeostatic
changes in protein expression.

Specific Aim 3: Test the hypothesis that ethanol-induced alterations in
FMRP-mediated translation are accompanied by changes in spine
morphology. Previous studies have shown that alterations in FMRP-mediated
protein expression are accompanied by changes in dendritic spine morphology.
These alterations appear to be mediated by Cyfip2. A naturally occurring genetic
polymorphism in two different C57BL/6 mouse lines provides the opportunity to
examine the connection between actin polymerization and protein translation.
Experiments conducted under this aim will discern whether these two processes
are linked in chronic ethanol exposure of if they can occur independently of one
another.
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Chapter 2

Exposure to chronic ethanol alters downstream
substrates of FMRP at dendritic spines

Background and Significance

Alterations at glutamatergic synapses in dendrites and dendritic spines in
the hippocampus during exposure to chronic ethanol function to reestablish
neuronal homeostasis (Calabrese et al 2006; Ramocki and Zoghbi 2008; Caljigas
et al 2010; Haft et al 2014). Evidence suggests that during chronic ethanol
exposure, prolonged inhibition of NMDA receptors induces homeostatic
mechanism to maintain proper neuronal function (Lovinger et al 1990; Kumari
and Ticku 2000; Carpenter-Hyland et al 2004; Hendrickson et al 2004; Tokuda et
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al 2007; Nagy 2008; Gladding and Raymond 2011) This long-term exposure
requires a less transient, more lasting change to balance excitation and inhibition
(Kumari and Ticku 2000; Jung et al 2008; Nagy 2008; Pian et al 2010). However,
the nature of these changes in the hippocampus, and how they are achieved are
not well understood.
Disorders defined by hyperexcitable states such as epilepsy and fragile X
syndrome provide evidence of a role not only for NMDA receptors, but also
inhibitory

proteins

responsible

for

dampening

local

excitatory

inputs

(Ruschenschmidt et al 2006; Monaghan et al 2008; Henry 2011; Fernandez and
Bagni 2008; Meng et al 2013; Russo et al 2013). In pyramidal neurons in the
hippocampus, the A-type K+- channel Kv4.2 and its auxiliary protein KChIP3 are
two of the main proteins that regulate glutamatergic inputs and balance excitation
(Lin et al 2004; Kim et al 2007; Carrasquillo et al 2012; Kunjilwar et al 2013;
Labno et al 2014). As some of the main regulators of excitability in dendrites and
dendritic spines in the hippocampus, these proteins are important for balancing
local glutamatergic inputs with the intracellular environment to prevent
hyperexcitability and neurotoxicity (Ruiz-Gomez et al 2006; Kim et al 2007;
Andrasfalvy et al 2008; Barnwell et al 2009; Carrasquillo 2013)
Maintaining long-term changes in homeostasis, in addition to alterations in
function, it also likely involves adjusting local protein expression. This requires
alterations in signaling cascades regulating protein synthesis and the
translational

machinery

itself

to

make

the

necessary

adjustments

to

glutamatergic function (Krug et al 1984; Klann and Richter 2007; Mercaldo et al
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2009; Sossin and Lacaille 2010; Kim et al 2013; Thomas et al 2013). Previous
studies indicate a potential role for substrates in the mTORC1 translational
pathway and one of its downstream components, the mRNA-binding translational
repressor protein, FMRP (Weiler et al 2004; Raab-Graham 2006; Costa-Mattioli
et al 2009; Ma and Blenis 2009; Darnell and Klann 2013). Treatment with the
mTORC1 inhibitor, rapamycin, blocks FMRP-mediated decreases in Kv4.2
expression in the hippocampus and prevents homeostatic increases in other
proteins at glutamatergic synapses, namely PSD-95 and CaMKII, in rat models of
chronic ethanol exposure (Gross et al 2011; Lee et al 2011; Barak et al 2013;
Takei and Hiroyki 2014).
FMRP expression and function is an important modulator of activitydependent changes in homeostatic signaling as well as overall basal protein
levels for a number of downstream targets, including those affected by ethanol
(Ramocki and Zoghbi 2008; Cajigas et al 2010; Henry et al 2011; Darnell et al
2013). As such, FMRP likely contributes to the homeostatic mechanism inducing
intracellular changes to compensate for the long-term effects of ethanol at
glutamatergic synapses. However, how FMRP alters translation, and which
proteins regulated by FMRP are altered by chronic ethanol exposure are not
known.
Studies presented in this chapter focused on determining which targets of
FMRP are altered by chronic ethanol exposure in the in vivo CIE mouse model
and in vitro organotypic hippocampal slice cultures. These studies also examined
the effect of chronic ethanol on FMRP activity and total protein levels in the
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hippocampus and investigate whether these ethanol-induced changes in protein
expression are consistent with alterations in FMRP-mRNA interactions during
long-term ethanol exposure.

Methods

Organotypic hippocampal slice culture ethanol exposure
Hippocampal slice cultures were prepared from P6-P8 Sprague-Dawley rats
as described in Mulholland et al 2014. In brief, pups were euthanized using either
ice or isofluorane, sacrificed, and both hippocampi dissected out on cold
dissecting media (500 ml Eagle’s Basal, 25 mM HEPES, 100 µg/ml Streptomycin,
2 mM Glutamax). Next hippocampi were sliced into 400 µm coronal sections and
placed with four slices per well onto an organotypic cell culture membrane in
culture media (50 ml Dissecting media, 36 mM glucose, 25% v/v Earle’s
Balanced Salt Solution, and 25% v/v heat inactivated horse serum). Cultures
were incubated with 7.5% CO2 at 37 oC in culture media for at least eight days,
and media was changed every 4 days. Following eight days of incubation, slices
were treated with 75 mM ethanol in regular culture media or media alone in
sealed vapor chambers. All experiments adhered to NIH Animal Care Guidelines
and were approved through the IACUC.

Protein Assay
Organotypic hippocampal slice cultures or hippocampal lystates from CIEtreated mice were sonicated in 2% LDS. A BCA protein assay kit (Pierce) was
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used to determine total protein content. Following sonication, standards with a
blank (0, 0.25, 0.5, 0.75, 1.0, 1.5, and 2.0) and samples at 1:10 ratio with LDS
were loaded in triplicate in a 96 well plate. Once complete, 9.8 ml of Reagent A
and 200 µl of Reagent B were mixed, and 200 µl of the combined solution was
added to each well. The plate was then incubated in the dark at 37 oC for 30
minutes. The concentration for each well was calculated using the Bio-Rad 550
MicroPlate Reader.

Western blot analysis
Protein samples were mixed using the NuPage Invitrogen western system
and then heated at 70 oC for 10 min. Proteins were separated via electrophoresis
on a 7.5% Bis-Tris gel, transferred onto a PVDF membrane using the Bio-Rad
semi-dry transfer, and a reversible Swift total protein stain was used to evaluate
loading and for normalization of the data. Following the total protein stain,
membranes were blocked in 4% non-fat milk, and incubated in primary antibody
at 4

o

C overnight. Primary antibodies used for these experiments are

phosphorylated S499 FMRP (1:1000), FMRP total protein (1:2000), KChIP3
(1:500), Kv4.2 (1:1000), GluN1 (1:3000), and GluN2B (1:3000). After primary
antibody incubation, membranes were incubated in secondary antibody, KChIP3
goat anti-rabbit and Kv4.2, GluN1, and GluN2B goat anti-mouse, for 1 hour at
room temperature. After secondary antibody incubation, membranes were
exposed to enhanced chemillumiscience using ChemicDoc MP Imaging System.
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Co-immunoprecipitation (co-IP) and RT-qPCR
Following treatment with ethanol, PF-4708671 (PF) or ethanol and PF4708671 concurrently (PF + EtOH), cultures were processed for either western
blot analysis or co-IP and RT-qPCR. Co-IP with mRNA solutions were adapted
from the procedures described by Lee et al 2011 and the protocol of the Pierce
Co-IP Kit. Using the resin and coupling spin columns from the Pierce Co-IP kit, 6
µg of FMRP antibody was used for every mg of beads, with 6-7 mg of beads per
spin column used for resin pre-clearing and antibody immobilization. AminoLink
coupling resin was added to the spin column followed by coupling buffer washes
(10 mM NaH2PO4, 150 mM NaCl in nuclease free water). Antibody for coupling
was added to the spin columns in coupling buffer and incubated at room
temperature for 120 minutes while slowly rotating. Following antibody coupling
incubation, quenching buffer (1 M Tris-HCl) was added to ensure proper coupling.
Hippocampal lysates were also pre-cleared with coupling buffer for 1 hr prior to
co-IP. Slice cultures were homogenized with a needle and syringe with RNase
and protease inhibitors in homogenization buffer (1.28 M sucrose, 40 mM TrisHCl pH 7.5, 20 mM MgCl2, and 1% NP-40, with ~ 2 ug/ml of RNasin Plus
inhibitors, and 1X cOmplete Mini EDTA-Free Protease Inhibitor). Hippocampal
lysates were cleared with control agarose resin (80 µl for every 1 mg of lysate).
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For lysate clearing, new columns were coated with coupling buffer, then lysate
and control resin were incubated in the column for 1 hour at 4 oC with gentle
mixing. Flow-through by centrifugation provided cleared lysate for co-IP
experiments. After antibody and lysate preclearing, co-IP with mRNA was
performed (all steps performed 4 oC).

Antibody-cleared spin columns were

rinsed with wash buffer (0.1M PBS, 200 mM NaCl, and 2µl/ml of RNase Plus and
1X protease inhibitor,), pre-cleared lysate added to spin column, and incubated
overnight at 4 oC. Columns were then rinsed with wash buffer, and FMRPmRNAs were eluded from the column with Elution Buffer from Pierce kit, and
mRNAs were then dissociated from FMRP with a TRIzol- chloroform extraction
(Lee et al 2011). In brief, 200 µl of chloroform per 1 ml of TRIzol was added to
each tube (1 ml TRIzol for every 75 mg of tissue), and incubated for 3 min at
room temperature. After incubation, samples were centrifuged at 12,000 xg for
15 min at 4 oC. The upper aqueous phase containing the mRNA was then
transferred to a separate tube.
mRNA was purified using the Qiagen RNeasy Mini Kit and nonspecific
cDNA was transcribed using the Applied Biosystems High Capacity RNA- to –
cDNA Kit (4387406). The reverse transcription reaction used a total volume of 20
µl at 37 oC for 60 minutes, 95 oC for 5 minutes, and a 4 oC hold (Bio-Rad C1000
thermocycler).

For qPCR, a Sybr Green qPCR kit on a Bio-Rad CFX 96

thermocycler was used with an initial denaturation of 2 min at 94 oC followed by
40 cycles with a 15 sec denaturation at 94 oC and 1 min of annealing and
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extension at 60 oC and a 4 oC hold. All primer sequences used are shown in
Table 1. A schematic of the co-IP protocol is provided in Figure 2-1.
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mRNA
GAPDH

Primer Sequence
5’- AAGGCTCATGACCA
3’- CAGGGATGATGTTCT

HPRT

5’ TTGGATACAGGCCAGACTTTGTT
3’ CTGAAGTACTCATTATAGTCAAGGGCATA

FAAH

5’- ATGAACCCGTGGAAGCCCTC
3’- CGCCGATGTCAGTGCCTAAAC

GluN1

5’- CTCTAGCCAGGTCTACGCTATCC
3’- GACGGGGATTCTGTAGAAGCCA

GluN2B

5’- CTGGAGTTCTGGTTCCTTACTG
3’- ATTCTCCTATCTTGCCCGGA

KChIP3

5’ CACCTATGCACACTTCCTCTTCA
3’ ACCACAAAGTCCTCAAAGTGGAT

Kv4.2

5’-GCCTTCGTTAGCAAATCTGG
3’ GTGACATAAGGACACTGGG

FMRP%mRNA)Interac1ons)Following)Chronic)Ethanol)Exposure))

Table 1. Primer sequences for RT-qPCR.

8"Day"EtOH"Treatment"

Co1"IP"FMRP"and"
mRNAs"

RNA"puriﬁca@on"and"RT"

qPCR"
Figure'2)1!Co$IP!Experimental!Paradigm.!

!
Organotypic!hippocampal!slice!cultures!are!treated!using!an!8$day!
exposure!paradigm.!Following!exposure,!FMRP!is!immunoprecipitated!
with!mRNAs.!The!puriﬁed!samples!then!undergo!a!nonspeciﬁc!reverse!
transcripFon!and!a!quanFtaFve!PCR!with!cDNA$speciﬁc!primers.!!'
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Chronic intermittent ethanol
Male C57BL/6J mice, approximately 9 weeks of age at the start of the
experiment, were housed in a climate-controlled vivarium with a 12-hour
light/dark cycle. Beginning approximately 3 hours into the dark cycle, mice were
exposed to either ethanol or air vapor for 14 hours, followed by an 8-hour
withdrawal period. This cycle of intermittent ethanol exposure was repeated for
four days. Following the last 14-hour exposure period of a 4-day cycle, animals
experienced a 72-hour withdrawal. All animals included in the study completed
four of these weeklong cycles of CIE exposure and withdrawal.

Statistical Analysis
Western blots were quantified using ImageJ software (National Institutes of
Health). Density of the appropriate band for each antibody was measured.
Background for each lane was subtracted from the band density and variations in
protein sample loading were normalized with a total protein stain, as previously
mentioned. Student t-tests were used to test for significant differences between
control and ethanol groups. Four-day timepoints are paired t-tests; samples from
each group for each n were taken from the same animal.
RT-qPCR experimental cDNAs were normalized against GAPDH for each
sample. Student t-tests were again used to evaluate significant differences
between the fold change for control and ethanol groups.
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Results

Homeostatic changes in protein expression at glutamatergic synapses

Acute ethanol decreases NMDA receptor function and local excitatory
inputs to dendritic spines in the hippocampus. In contrast, prolonged exposure to
ethanol induces mechanism to counteract the chronic inhibition and maintain
proper excitatory function (Lovinger et al 1990; Kumari and Ticku 2000; Nagy
2008; Korkotian et al 2013; Talani et al 2013). However, the nature of these
changes has not been characterized.
To evaluate changes in protein expression at glutamatergic synapses,
western blot analysis was used to define differences in NMDA receptor subunit
expression

in

chronic

intermittent

ethanol

(CIE)-exposed

mice.

Whole

hippocampal homogenates were tested for GluN1 and GluN2B expression. As
shown in Figure 2-2, in mice exposed to CIE, hippocampal tissue showed an
increase in total GluN1 receptor expression as well as increases in GluN2B
expression (GluN1: t test, t(20)= 2.146, * p< 0.05, n= 11; GluN2B: t test, t(20)=
2.132, * p< 0.05, n=11).
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Figure'2)2''Ethanol(induced.changes.in.NMDA.receptor.subunits.in.the.
mouse.hippocampus...
..
Chronic.intermi;ent.ethanol.exposure.increased.both.GluN1.and.GluN2B.
total.protein.expression.in.the.mouse.hippocampus..(n=.11.,..*p<.0.05).'

In addition to changes in NMDA glutamate receptors, balance in excitation
also involves alterations in proteins that mediate hyperexcitability; this includes
the A-type K -channel Kv4.2 and its auxiliary protein KChIP3. Again, western blot
+

was used to evaluate changes in Kv4.2 and KChIP3 protein expression in the
same CIE mouse model. Immunoblot analysis of total protein expression showed
a decrease in Kv4.2 expression (Figure 2-3). Blots for KChIP3 also revealed a
decrease in protein expression, suggesting ethanol alters both excitatory and
inhibitory proteins to maintain neuronal homeostasis (Kv4.2: t test, t(16)=2.121,
*p<0.05, n = 9; KChIP3: t test, t(18)=2.123, *p<0.05, n= 10).
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Figure"2*3.%Altera-ons%in%Kv4.2%and%KChIP3%a;er%chronic%intermi>ent%ethanol%
exposure.%
%

Mouse%hippocampal%-ssue%from%ethanolDtreated%animals%showed%a%decrease%in%
Kv4.2%and%KChIP3%expression%(n=%10,%*p<%0.05).%%"

In order to further investigate the mechanisms driving these changes,
protein expression in the organotypic hippocampal slice culture model was
evaluated to confirm consistency with the CIE in vivo paradigm. As before, using
western blot, NMDA receptor subunit expression was measured by western blot.
At a dose of 75 mM ethanol, GluN1 protein levels were increased, thus
replicating the observations obtained in CIE- exposed mice. This increase
occurred after 8 days of exposure, but it was not seen with an acute exposure
period of 24 hours with the same dose. Although there was a slight increase in
GluN1 subunit expression after 4 days of exposure, this was not significant
(Figure 2-4; GluN1: 24 hr: t test, t(4)=1.217, p= 0.2903, n= 5; 4-day: t test,
t(3)=2.822, p= 0.0667, n= 6, 5; 8-day: t test, t(10)=2.997, *p<0.05, n= 6). In
addition to GluN1, GluN2B protein levels were also measured. A time-course
80

treatment with 75 mM ethanol also induced an increase in GluN2B. Similar to
GluN1, this increase was not seen after 24 hours of ethanol exposure, but was
significantly increased following both 4- and 8-day exposure paradigms (Figure
2-4; GluN2B: 24 hr: t test, t(4)=1.295, p= 0.1325, n= 5; 4-day: t test, t(4)=2.796,
*p<0.05, n= 5; 8-day: t test, t(12)=2.612, *p<0.05, n= 7).
As with the in vivo model, western blot was also used to evaluate changes
in total protein levels of Kv4.2 and KChIP3. These proteins also mimicked results
from CIE animals and exhibited a decrease in protein expression after both 4 and
8 days of ethanol exposure. Time course experiments revealed that these
changes were limited to the longer exposure periods of 4 and 8 days (Figure 2-5;
Kv4.2:

24 hr: t test, t(4)=0.2454, p= 0.4091, n= 5; 4-day: t test, t(4)=2.960,

*p<0.05, n= 5; 8-day: t test, t(12)=2.174, *p<0.05, n= 7; KChIP3: 24 hr: t test,
t(4)=1.405, p= 0.1163, n= 5; 4-day: t test, t(5)=3.588, *p<0.05, n= 5,6; 8-day: t
test, t(10)=3.016, *p<0.05, n= 6).
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Figure"2+4.""Time%course%of%changes%in%NMDA%receptor%subunits%
following%acute%and%chronic%ethanol%exposure%in%hippocampal%slice%
cultures.%%%

%
%A."GluN1%expression%was%signiﬁcantly%increased%a@er%8%days%of%ethanol%

exposure,%but%not%4%days%or%24%hours%(n=%6,%5%%%p<%0.05).%%B."Expression%of%
GluN2B%was%signiﬁcantly%increased%at%both%4%and%8%days,%but%not%a@er%24%
hours%(n=%6,%5%%%p<%0.05)."
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Figure"2+5.""Ethanol)induced/changes/in/Kv4.2/and/KChIP3/expression/
in/organotypic/hippocampal/slice/cultures.///

/

Both/Kv4.2/(A)"and/KChIP3/(B)"total/protein/expression/was/signiﬁcantly/
decreased/following/both/4/and/8/days/of/ethanol/exposure,/but/no/
change/was/seen/aGer/24/hours/(n=/5,/5,/6//*p</0.05)."
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Ethanol-induced changes in FMRP expression and function

Chronic ethanol drives homeostatic changes at glutamatergic synapses to
maintain optimal excitatory signaling. However, the mechanism underlying these
changes remains unknown. One potential candidate in this process is the mRNAbinding protein FMRP. FMRP has previously been shown to regulate translation
of Kv4.2, KChIP3, and NMDA receptor subunits (Jones 2003; Henry et al 2011;
Darnell et al 2011). Increases in phosphorylation of FMRP at S499 are
associated with an increase in FMRP-mRNA interaction, and therefore, a
decrease in protein expression (Laggerbauer et al 2001; Ceman et al 2003; Zalfa
et al 2006; Darnell and Klann 2013; Bartley et al 2014).
To evaluate total and phosphorylated FMRP protein expression, western
blot analysis was used in CIE-exposed mouse hippocampal tissue. A phosphospecific antibody for S499 revealed an increase in expression of phospho-FMRP
protein in the ethanol-exposed mouse hippocampus compared to controls.
However, there was no change in total FMRP protein levels (Figure 2-6;
phospho-FMRP: t test, t(40)=2.382, *p<0.05, n= 21; FMRP: t test, t(35)=0.0997,
p=0.9211, n= 18,19). In the in vitro model culture system, western blot was also
used to determine changes in phosphorylated and total FMRP protein following
different ethanol exposure time points. Similar to changes observed following in
vivo exposure, there was an increase in phosphorylated FMRP in cultures
treated with ethanol, but again no change in total FMRP protein expression.
However, unlike observations with NMDA receptor subunits proteins, this
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increase was seen acutely after only 24 hours of exposure and persisted
throughout the longer exposure periods of 4 and 8 days (Figure 2-7; phosphoFMRP: 24 hr: t test, t(6)=2.474, *p<0.05, n= 6; 4-day: t test, t(3)=2.848, *p<0.05,
n= 5, 6; 8-day: t test, t(5)=3.149, *p<0.05, n= 6; 8-day+24 hr withdrawal: t test,
t(6)=2.635, *p<0.05, n= 6). Additionally, 8 days of ethanol exposure followed by
24 hours of acute withdrawal produced the opposite effect, with a significant
decrease in phosphorylated FMRP protein while total protein levels remain
unchanged (Figure 2-7 FMRP: 24 hr: t test, t(4)=0.2356, p= 0.4191, n= 5; 4-day:
t test, t(4)=0.2356, p= 0.4191, n= 5; 8-day: t test, t(5)=0.7408, p=0.4921, n= 6; 8
–day+24 hr withdrawal: t test, t(6)=0.8217, p=0.4427, n= 6). This increase was
represented by an increase in phosphorylated FMRP, and not a general increase
in total protein expression (Figure 2-8; t test, t(5)=2.672, *p<0.05, n= 3).
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Figure'2)6""Chronic"intermi-ent"ethanol0induced"diﬀerences"in"
phosphorylated"and"total"FMRP"protein"in"the"mouse"hippocampus."

"

Exposure"to"chronic"ethanol"increased"phosphorylated"FMRP"levels,"
but"did"not"change"total"protein."(n="21,"18,"19"*"p<"0.05)'
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Figure"2+7!!Time!course!of!phosphorylated!and!total!FMRP!expression!in!
hippocampal!slice!cultures.!!

!
!A."Phosphorylated!FMRP!was!increased!at!three!;mepoints!a<er!ethanol!

exposure:!!24!hours,!4!days,!and!8!days.!However!following!8!days!of!
exposure!and!a!24!hour!withdrawal!period,!phosphorylated!FMRP!protein!
was!signiﬁcantly!decreased!(n=!5,6!!*!p<!0.05).!!B."Unlike!phosphorylated!
FMRP!protein!expression,!total!protein!levels!remained!unchanged!during!
all!three!exposure!;me!points!and!following!acute!withdrawal!!(n=!5,6!!*!p<!
0.05)."
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changes in expression of these
proteins. For these experiments,
organotypic hippocampal slice
cultures was used to investigate
changes

in

FMRP-

mRNA

binding under control and ethanol-exposed conditions. Using co-IP and RTqPCR, FMRP with bound mRNAs were pulled down, purified, and amplified with
cDNA-specific primers (Figure 2-1). Previous studies in rat models of chronic
ethanol have confirmed increases in PSD-95 protein expression (Barak et al
2013). As one of the first, and most widely researched FMRP targets, PSD-95
mRNAs were used as confirmation that mRNA binding to FMRP was preserved
using this paradigm, and western blot analysis was used to as a positive control
to confirm successful pull down of FMRP (Figure 2-9; PSD-95: t test, t(5)=2.672,
*p<0.05, n= 3). It is important to note that decreased FMRP-mRNA associations
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are indicative of an increase in translation, and therefore, an increase in protein
expression. In the hippocampal slice cultures, PSD-95 mRNA binding to FMRP is
significantly decreased following 8-day ethanol exposure. This suggests that
FMRP may also mediate expression of other proteins implicated in ethanolinduced homeostatic changes.
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Figure(2*9(((Successful%pull%down%of%mRNA%with%FMRP.%%
(

A.(A%signiﬁcant%decrease%in%PSDD95%mRNA%pulled%down%with%
FMRP%(n=%4,%*p%<%0.05).%B.%Western%blot%of%pooled%samples%
pulled%down%using%the%FMRP%anQbody.%Samples%incubated%
with%the%anQbody%only%and%no%protein%showed%only%the%IgG%
band.%However,%both%control%and%ethanolD%treated%groups%
showed%bands%for%FMRP%and%IgG%(n=%4).%(

ethanol-exposed

slices

compared

to

controls.

However,

analysis

of

GluN2B show a decrease
in FMRP-GluN2B mRNA

binding (Figure 2-10; GluN1: t test, t(7)=0.9546, p=0.3716, n= 8; GluN2B: t test,
t(8)=2.402, *p<0.05, n= 9; Kv4.2: t test, t(8)=2.340, *p<0.05, n= 9; KChIP3: t test,
t(7)=2.561, *p<0.05, n= 6). In addition to these mRNAs, others coding for
proteins that influence inhibitory signaling were also measured, including Kv4.2
and KChIP3. Co-IP and subsequent RT-qPCR showed an increase in FMRP
binding to both Kv4.2 and KChIP3 mRNAs. This increase in association indicates
an increase in FMRP- mRNA interaction, and therefore an increase in inhibition.
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This also suggests a decrease in Kv4.2 and KChIP3 mRNA translation and
protein expression.
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Discussion

The main findings of this chapter are that chronic ethanol exposure induces
homeostatic, bidirectional changes in protein expression in dendrites and
dendritic spines that may function to reestablish the balance between excitation
and inhibition. Furthermore, these changes in protein translation correspond to
alterations in FMRP activity and mRNA interactions. These results suggest that
restoring homeostasis during exposure to chronic ethanol is a multifaceted,
coordinated effort that requires adjustments in both excitation and inhibition.
However, components of these systems may share a common translational
pathway with FMRP, and increased FMRP activity may be an essential
component of ethanol-induced changes in protein expression.
Previous results have shown that long-term ethanol exposure promotes
excitation at glutamatergic synapses and dampens inhibition (Lovinger 1990;
Hendricson et al 2007; Korkotian et al 2013; Zorumski et al 2014). This increase
in glutamatergic signaling is not limited to increases in NMDA receptors, and
likely involves a reduction in local inhibitory proteins in dendrites and dendritic
spines. Results presented in this chapter confirm a chronic ethanol-induced
increase in GluN1 and GluN2B subunit expression in the hippocampus following
both in vitro and in vivo chronic ethanol exposure. Previous studies from our lab
indicate that this increase in NMDA receptor expression is specific for GluN2Bcontaining NMDA receptors, and GluN2A expression remains unchanged
(Carpenter-Hyland et al 2004). Functionally, this shift may have important
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implications in altered plasticity and excitability in response to chronic ethanol
exposure. Previous studies in Huntington’s disease, fragile X syndrome, and
epilepsy have shown that specifically GluN2B-containing NMDA receptors are
important for the development of this hyperexcitable phenotype, and suppression
of GluN2B dampens NMDA-mediated cell death in hippocampal primary cultures
(Monaghan et al 2008; Lei et al 2010; Russo et al 2013). Taken together with
these previous functional studies, in GluN2B-containing NMDA receptors may
have a key contribution to the increased excitability induced by chronic ethanol
exposure.
These results also suggest an important role for Kv4.2 and the auxiliary
protein

KChIP3

in

mediating

ethanol-induced

hyperexcitability

in

the

hippocampus. Results presented here confirm other studies from our lab found
that shows a decrease in Kv4.2 channel expression following chronic ethanol
exposure. Additionally, previously published work demonstrated a decrease in Atype current following chronic ethanol that is not attributed to other A-type K +

channels, such as Kv1.4 (Mulholland et al 2014). As one of the main influences
dampening excitatory inputs, Kv4.2 has a well-defined role in epileptogenesis
and hyperexcitability in the hippocampus (Hong et al 2003; Monaghan et al 2008;
Aronica et al 2009; Barnwell et al 2009). It is also of note, that Kv4.2 may have
an important role in NMDA-mediated hyperexcitability. Interestingly, increases in
GluN2B-containing NMDA receptors is associated with decreases Kv4.2mediated A-type current as well as Kv4.2 expression (Kim et al 2007; Lei et al
2008; Lei et al 2010). As such, Kv4.2 likely has an integral role in maintaining
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homeostatic increases in excitability and reduction in Kv4.2 expression that may
reflect a coupled homeostatic response with the increase in GluN2B expression.
In addition to a reduction in expression of Kv4.2, our results also show a
decrease in KChIP3 protein expression. Importantly, KChIP3 is integral in finetuning Kv4.2 channel kinetics and is necessary for Kv4.2 channel surface
expression (Shibata et al 2003; Lin et al 2004; Menegola et al 2006 Ruiz-Gomez
et al 2006). Previous studies in our lab have shown that this ethanol-induced
decrease in expression of Kv4.2 channels is limited to surface-expressed protein
(Mulholland et al 2014). Taken together, this suggests that the decrease in
KChIP3 contributes to the decreased surface expression of Kv4.2. In addition to
Kv4.2, KChIP3 may also contribute to the increased excitation resulting from
chronic exposure. KChIP3 interacts either directly with the GluN1 or GluN2B
subunit to decrease NMDA surface expression, or indirectly by binding to PSD95 and decreasing NMDA-mediated current (Zhang et al 2010; Wang et al 2012).
Therefore, this ethanol-induced decrease in KChIP3 may have an important role
in both excitation and inhibition during chronic ethanol exposure.
These data also provide insight into how ethanol may alter neuronal
homeostasis by mediating local translation in dendrites and dendritic spines.
Ethanol exposure resulted in an increase in FMRP phosphorylation at S499 in
both acute and long-term exposure paradigms with high dose ethanol. However,
ethanol-induced changes in other proteins of interest were not seen after a shortterm 24-hour exposure period, only after a longer 8-day exposure. This increase
in FMRP phosphorylation after acute ethanol exposure may reflect changes in
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other FMRP-mediated translational mechanism for short-term adaptations.
Studies in seizure disorders, such as epilepsy, have shown that although there is
an increase in FMRP after 30 minutes. However, more sustained changes in
protein expression of its binding partners may occur between 2 and 48 hours
after the initial induction of seizure activity (Price and Ring 2011; Meng et al
2013; Russo et al 2013). Conversely, phosphorylation at S499 was significantly
decreased following a 24-hour withdrawal period after an 8-day ethanol treatment.
Acute withdrawal periods following long-term exposure are characterized by
increased NMDA-mediated hyperexcitability that can lead to withdrawal-induced
seizures (Hall and Zador 1997; Duka et al 2004; Hendricson et al 2007). This
decrease in phosphorylation may be indicative of the need for an immediate shift
in translational mechanisms or protein expression to correct the imbalance
caused by an acute withdrawal of ethanol. Taken together, these results suggest
that FMRP may mediate both short-term and long-term, homeostatic changes in
the hippocampus during ethanol exposure.
Increases in FMRP phosphorylation as a result of ethanol exposure are
indicative of changes in activity. However, FMRP may regulate different aspects
of translation, and it has a multitude of interacting partners in dendrites and
dendritic spines (Laggerbauer et al 2001; Ascano et al 2012; Darnell and Richter
2012). Therefore, it is informative to discern whether there is a difference in the
mRNAs corresponding to the proteins of interest bound to FMRP during control
and ethanol-treated conditions. Results in these studies revealed changes in
FMRP- mRNA binding as a result of 8-day ethanol exposure. These experiments
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show an increase in Kv4.2 and KChIP3 mRNAs bound to FMRP and a decrease
in GluN2B, but not GluN1 following long-term ethanol treatment. These data
suggest that FMRP directly modulates Kv4.2, KChIP3, and GluN2B translation
during ethanol exposure. As previously mentioned, the composition of NMDA
receptor subunits may affect not only NMDA-mediated hyperexcitability, but also
Kv4.2 expression and function (Lei et al 2008; Kaufmann et al 2012). In these
experiments, ethanol affects GluN2B, but not GluN1 FMRP-mRNA binding.
During chronic ethanol exposure, FMRP may have a more pronounced effect on
NMDA channel function by modulating subunit expression and therefore
composition, rather than affecting overall NMDA receptor expression.
Experiments in this chapter have confirmed that multiple factors contribute
to the maintenance of homeostasis at glutamatergic synapses. Increases in
NMDA receptor expression promote excitability and glutamatergic signaling,
while decreases in Kv4.2 and KChIP3 dampen excitation. Additionally both of
these mechanisms may be mediated by FMRP activity. Further experiments
presented in the next chapter will define whether FMRP activity is necessary for
ethanol-induced alterations in protein expression.
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Chapter 3

Inhibition of FMRP phosphorylation prevents
ethanol-induced translational changes in the
hippocampus

Background and Significance

FMRP protein expression and activity are important in maintaining basal
protein levels and regulating activity-dependent translation in dendrites and
dendritic spines (Bardoni et al 1997; Antar et al 2005; Dictenberg et al 2008;
Henry et al 2011). The absence of FMRP causes an increase in basal protein
levels as well as dysregulated synaptic plasticity in both clinical studies and fmr1-
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/- mouse models (Hagerman and Strafstorm 2009; Gross et al 2011; Krueger and
Bear 2011; Lee et al 2011; Maurin et al 2014; Chen and Joseph 2015). The role
of FMRP in regulating cellular function throughout development and in certain
pathological states is relatively well characterized. However, how FMRP
maintains basal protein levels and activity-dependent translation in a typically
functioning adult brain is unknown. Studies in Chapter 2 of this dissertation
demonstrated ethanol-induced changes in FMRP phosphorylation and alterations
in FMRP-mRNA interactions, supporting the suggestion that chronic ethanol
exposure induces an increase in FMRP activity. These results also implicated
certain mRNA targets of FMRP in ethanol-induced synaptic plasticity that are key
mediators of local excitation in dendritic spines, including Kv4.2, KChIP3, and
NMDA receptor subunits. These changes in protein expression represent longer,
homeostatic adaptations that are not induced by short-term exposure, even at
high doses, and this longer exposure period causes significant changes in
FMRP-mRNA interactions for these proteins of interest. Although FMRP activity
is altered by chronic ethanol treatment, it is important to determine if these
changes in FMRP phosphorylation and mRNA binding are necessary for the
homeostatic alterations in protein expression, and to investigate how ethanol
might induce these changes in FMRP function. Translation in dendrites and
dendritic spines is a highly coordinated process that involves several
components that are discretely regulated in order to maintain proper function at
the synapse (Kapp and Lorsch 2004; Weiler et al 2004; Sossin and Lacaille
2010; Hinnebusch and Lorsch 2012).
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One of the main intracellular pathways regulating local dendritic translation
is the mTORC1 signaling cascade. Studies from other groups have
demonstrated an important role for other mTORC1 substrates, namely p70
ribosomal S6 kinase 1 (S6K1), in mediating changes in protein expression
following chronic ethanol exposure in vivo (Holz et al 2005; Nesta 2010; Barack
et al 2013). Results from these studies revealed disruption of mTORC1 activity
during ethanol treatment prevents ethanol-seeking behaviors and memory
deficits (Nesta et al 2010; Barak et al 2013; Nesta et al 2014). Rats exposed to
chronic intermittent ethanol have significantly fewer active lever presses in a
standard reinstatement paradigm when treated with the mTORC1 inhibitor
rapamycin (Nesta et al 2010; Barak et al 2013) Additionally, rapamycin also
blocked ethanol-induced changes in expression of other proteins in dendritic
spines that are regulated by FMRP (Nesta et al 2010; Barak et al 2013).
Although these results suggest FMRP and its upstream mediators may play
an integral role in mediating translational changes during chronic ethanol
exposure, it is unclear if this change in activity is necessary for ethanol-induced
translation. Since mTORC1 and its substrates comprise one of the main
pathways regulating protein synthesis in response to changes in synaptic activity,
components of this pathway, including S6K1 and FMRP, are likely mediators of
ethanol-induced synaptic plasticity. During CIE, increased S6K1 activity via
mTORC1 activation may regulate increased FMRP phosphorylation at S499.
This increase in phosphorylation induces binding to select mRNAs to decrease
translation of these specific proteins while other FMRP-mRNA interactions are
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reduced, resulting in increased protein expression (Figure 3-1). Studies
presented in this chapter investigated whether increased FMRP phosphorylation
is necessary for ethanol-induced changes in protein expression, and whether
these changes in phosphorylation are mediated through S6K1 activity.
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Methods

Organotypic hippocampal slice culture ethanol exposure
Hippocampal slice cultures were prepared from P6-P8 Sprague- Dawley
rats, as described in Chapter 2. After plating hippocampal slice cultures were
incubated in culture media for at least eight days before treatment. All
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experiments adhered to NIH Animal Care Guidelines and were approved through
the IACUC. Slice cultures were exposed to 75 mM ethanol, 6 uM PF-4708671
(PF), or both for 8 days.
For S6K1 inhibition, a dose-response curve determined that 6 µM PF was
the concentration that inhibited FMRP phosphorylation, but did not alter other
downstream substrates. Therefore, this concentration was used in subsequent
experiments. The inhibitor, PF-4708671 was added to culture media daily
concurrent with ethanol exposure. After exposure, slices were scraped from the
culture membrane, sonicated in 2% LDS, and prepared for either western blot
analysis, or co- immunoprecipitation and RT-qPCR. See Chapter 2 for extended
methods.

Protein Assay
Organotypic hippocampal slice cultures were sonicated in 2% LDS. A BCA
Pierce Protein Assay Kit was used to determine total protein content as
described in Chapter 2.

Western blot analysis
Both mouse hippocampal tissue and organotyipc hippocampal slice cultures
were

sonicated

in

2%

LDS.

Protein

samples

were

separated

using

electrophoresis, transferred to a PVDF membrane, and a reversible Swift total
protein stain was used for normalization. Primary antibodies used were
phosphorylated S499 FMRP (1:1000), KChIP3 (1:500), Kv4.2 (1:1000), GluN1
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(1:3000), and GluN2B (1:3000). After primary antibody incubation, membranes
were incubated in secondary antibody: phosphorylated FMRP and KChIP3 in
goat anti-rabbit and FMRP, Kv4.2, GluN1, and GluN2B in goat anti-mouse for 1
hour at room temperature. After secondary antibody incubation, membranes
were exposed to an enhanced chemillumiscence and imaged with a ChemicDoc
MP Imaging System (Bio-Rad, Hercules, CA). See Chapter 2 for extended
methods.

Co- immunoprecipitation (co-IP) and RT-qPCR
Following treatment with ethanol, PF, or both, cultures were processed for
either western blot analysis or co-IP and RT-qPCR. Co-IP with mRNA solutions
were adapted from Lee et al 2011 and Pierce co-IP Kit. For co-IP, 6 µg of FMRP
total protein antibody was used for every mg of beads, with 6-7 mg of beads per
spin column. AminoLink coupling resin was added to spin column followed by
coupling buffer washes. Antibody for coupling was added to the spin columns in
coupling buffer and incubated at room temperature for 120 minutes with slow
rotation. Hippocampal lysates were also pre-cleared prior to co-IP. After antibody
and lysate preclearing, co-IP with mRNA was performed (all steps kept at 4 C).
o

Columns were then rinsed with wash buffer, and FMRP-mRNAs were eluded
from column with Elution Buffer from the Pierce kit, and mRNAs were dissociated
from FMRP with a TRIzol- chloroform extraction (Lee et al 2011). Next, mRNA
was purified using the Qiagen RNeasy Mini Kit and nonspecific cDNA was
transcribed using the Applied Biosystems High Capacity RNA- to –cDNA Kit. For
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qPCR, the Sybr Green qPCR kit was used on a Bio-Rad CFX 96 thermocycler
with an initial denaturation of 2 min at 94 oC followed by 40 cycles with a 15 sec
denaturation at 94 oC and 1 min of annealing and extension at 60 oC and a 4 oC
hold. All experimental data were normalized to GAPDH. The primer sequences
used are presented in Table 1; Chapter 2. Refer to Chapter 2 for detailed
methods.

Statistical Analysis
Experiments with control and either PF or Veh groups were analyzed with a
student t-test with significance p < 0.05. For experiments with S6K1 inhibitor (PF4708671) and concurrent ethanol treatment, a one-way ANOVA was used to
determine significance.

Results

Inhibition of specific S6K1 substrates

In the previous chapter, experiments addressed whether ethanol alters
FMRP protein expression and activity. Results presented here address how
ethanol may alter FMRP phosphorylation, and whether this increase in
phosphorylation is necessary for the homeostatic changes in protein expression
following chronic ethanol exposure. Specifically, these experiments investigate
whether S6K1 phosphorylates FMRP at S499, and if blockade of FMRP
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phosphorylation through S6K1 inhibition will prevent ethanol-induced changes in
FMRP-mRNA binding and protein expression. Importantly, treatment with the 6
µM dose of the S6K1 inhibitor, PF-4786071, did not significantly alter other
necessary downstream components of the S6K1 translational pathway. These
include S6, which is required for assembly of the pre-initiation complex, and
eIF4E, the mRNA cap-binding protein that is necessary to begin active
translation (Figure 3-2; phospho-S6: t test, t(4)=0.3946, p= 0.7133 n= 3; eIF4E: t
test, t(4)=1.081, p= 0.3403 n= 3; GluN1: t test, t(4)=0.8478, p= 0.4443 n= 3;
GluN2B: t test, t(4)=0.2354, p= 0.8255 n= 3; Kv4.2: t test, t(4)=0.04028, p=
0.9698 n= 3; KChIP3: t test, t(4)=0.3239, p= 0.7623 n= 3).
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Figure'3)2!!Under!control!condi,ons!blockade!of!S6K1!did!not!alter!expression!of!
downstream!substrates.!''
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A.!Long>term!treatment!with!PF>4708671!did!not!signiﬁcantly!alter!key!substrates!of!S6K1!that!
are!necessary!for!protein!transla,on!(n=!3,!p!>0.05).!!B.!Vehicle!(DMSO)!treatment!alone!did!
not!alter!expression!of!the!proteins!of!interest!with!the!8>day!paradigm!(n=!3,!p!>0.05).!!
Ctrl:!Untreated!slices;!PF:'S6K1!inhibitor;'Veh:!DMSO'
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Organotypic hippocampal slice cultures and western blot were used to first
characterize the S6K1-specific inhibitor (PF) in both ethanol-treated and
untreated neuronal cultures. In an 8-day ethanol exposure paradigm, treatment
with PF or concurrent PF + ethanol treatment significantly decreased FMRP
phosphorylation levels compared to ethanol only. However, neither group varied
significantly compared to controls (Figure 3-3; phospho-FMRP: one-way ANOVA,
F(3,12)= 6.174 p= 0.0062, Tukey post hoc, *p<0.05, n= 5).
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Figure'3)3!!Inhibi'on!of!FMRP!phosphoryla'on!through!blockade!of!S6K1!
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A.!The!S6K1!inhibitor!disrupts!S6K1!ac'vity,!but!does!not!alter!upstream!
regulators!including!mTORC1.!B.!Treatment!with!an!S6K1!inhibitor,!
PFG4786071,!decreased!FMRP!phosphoryla'on!levels!!(n=!5,!*!p<!0.05,!!**!p<!
0.001).!!
Ctrl:!Untreated!slices;!EtOH:!Ethanol!treatment!only;!PF:!S6K1!inhibitor!only;!
PF+'EtOH:'S6K1!inhibitor!and!ethanol!treatment.'
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Effect of S6K1 inhibition on protein expression

Using the same 8-day ethanol exposure paradigm, the effects of exposure
to the S6K1 inhibitor were evaluated for ethanol-induced alterations in NMDA
receptor subunits. Ethanol treatment alone produced the expected effect of an
increase in GluN1 subunit expression (Figure 3-4; GluN1: one-way ANOVA,
F(3,12)= 3.324 p= 0.0567, Tukey post hoc, *p<0.05, n= 5). However, PF alone
and PF with 75 mM ethanol did not significantly decrease GluN1 protein levels
compared to ethanol alone.
GluN2B total protein expression was also evaluated using western blot.
Similar to GluN1, there was a significant increase in protein expression with
ethanol treatment only. Addition of PF to the culture media alone did not
significantly change expression levels from either control or ethanol-treated
tissue. When PF and ethanol were added to hippocampal slices in combination,
GluN2B protein expression decreased significantly compared to ethanol- treated
tissue, but did not show a significant change compared to controls (Figure 3-4
GluN2B: one-way ANOVA, F(3,12)= 5.665 p= 0.0.0272, Tukey post hoc, *p<0.05,
n= 5).

105

PF&+&
Ctrl& EtOH& PF& EtOH&

A&
120
100
80
60
40
20
0

Ctrl

GluN2B&
120

*
Relative Density
(total protein)

Relative Density
(total protein)

B&

GluN1&

EtOH

PF

PF&+&
EtOH&

*&

*

100
80
60
40
20
0

PF +
EtOH

Ctrl& EtOH& PF&

Ctrl

EtOH

PF

PF +
EtOH

Figure'3)4!Inhibi'on!of!FMRP!phosphoryla'on!alters!ethanol6induced!changes!in!NMDA!
receptor!subunit!expression.!!

!

A.!Inhibi'on!of!FMRP!phosphoryla'on!did!not!signiﬁcantly!alter!ethanol6induced!changes!in!
GluN1!receptor!expression!(n=!5,!*!p<!0.05).!B.!Decreased!FMRP!phosphoryla'on!
signiﬁcantly!prevented!the!ethanol6induced!increase!in!GluN2B!expression.!(n=!5,!*!p<!0.05).!!!!
Ctrl:!Untreated!slices;!EtOH:!Ethanol!treatment!only;!PF:!S6K1!inhibitor!only;!PF+'EtOH:'S6K1!
inhibitor!and!ethanol!treatment.'

In addition to NMDA receptor subunits, Kv4.2 and KChIP3 protein levels
were also investigated with inhibition of FMRP phosphorylation. Consistent with
results from Chapter 2, ethanol alone caused a significant decrease in
expression of both Kv4.2 and KChIP3 (Figure 3-5; Kv4.2: one-way ANOVA,
F(3,12)= 5.509 p= 0.0148, Tukey post hoc, *p<0.05, n= 5; KChIP3: one-way
ANOVA, F(3,12)= 6.174 p= 0.0.146, Tukey post hoc, *p<0.05, n= 5). However,
this decrease in Kv4.2 and KChIP3 expression was prevented by exposure to PF.
Additionally, KChIP3 protein levels with S6K1 inhibition alone were significantly
decreased compared to ethanol alone, but were not different compared to control
slices. Kv4.2 expression with S6K1 inhibition, however, was unchanged
compared to both controls cultures and ethanol-treated slices.
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A.!Treatment!with!an!S6K1!inhibitor!blocked!the!reducCon!in!Kv4.2!channel!expression!
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Alterations in FMRP-mRNA ethanol-induced interactions following S6K1
inhibition

Changes in protein expression with inhibition of FMRP phosphorylation via
decreases in S6K1-mediated activity is consistent with a potential role for FMRP
in translational changes during chronic ethanol-induced plasticity. To further
examine direct FMRP-mRNA interactions, we again used co-immunoprecipitation
of FMRP-mRNA complexes followed by RT-qPCR analysis of GluN1, GluN2B,
Kv4.2, and KChIP3. As shown in Figure 3-6, these results corresponded to the
changes in protein expression. GluN1 mRNA bound to FMRP was not significant
following ethanol treatment alone, confirming observations in Chapter 2. In the
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western blot experiments with PF treatment, none of the other treatment groups,
PF or PF + ethanol, were significantly different compared to controls or ethanol
alone. However, as seen in previous experiments, GluN2B mRNA bound to
FMRP in ethanol-treated cultures was significantly reduced compared to controls
alone. Treatment with the S6K1 inhibitor blocked ethanol-induced decreases in
GluN2B mRNAs. PF alone did not significantly alter mRNA levels compared to
either control or ethanol alone (Figure 3-6; GluN1: one-way ANOVA, F(3,12)=
0.3996 p= 0.7558, n= 5; GluN2B: one-way ANOVA, F(3,15)= 4.232 p= 0.0235,
Tukey post hoc, *p<0.05, n= 6).
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In addition to NMDA receptor subunits, other mRNAs bound to FMRP that
are affected by chronic ethanol exposure were tested. Kv4.2 mRNA coprecipitated with FMRP was increased following an 8-day ethanol treatment,
replicating previous observations (Figure 3-7; Kv4.2: one-way ANOVA, F(3,12)=
3.630 p= 0.0351, Tukey post hoc, *p<0.05, n= 5). Treatment with the S6K1
inhibitor alone did not significantly change protein levels compared to either
control or ethanol-treatment tissue. Addition of PF blocked ethanol-induced
increases in Kv4.2 mRNA and FMRP binding.
Expression of the Kv4.2 auxiliary protein KChIP3 was also evaluated. As
with Kv4.2, the addition of ethanol to the culture media caused an increase in
KChIP3 mRNAs interacting with FMRP, again consistent with results presented
Chapter 2. Importantly, treatment with PF in combination with ethanol prevented
the ethanol-induced increase in interactions (Figure 3-7; KChIP3: one-way
ANOVA, F(3,12)= 4.465 p= 0.0252, Tukey post hoc, *p<0.05, n= 5). While PF
alone did not cause any change in protein expression compared to control tissue,
there was a significant decrease mRNAs compared to controls.
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Discussion

Data presented in this chapter demonstrated that ethanol-induced increases
in FMRP phosphorylation at S499 underlie ethanol-induced homeostatic changes
in protein expression in the hippocampus. These studies also suggest a
mechanism by which ethanol causes these increases in FMRP phosphorylation
through activation of S6K1.
Results from Chapter 2 suggest that FMRP is an integral component of
activity-dependent translation by increases in phosphorylation of S499 of FMRP,
changes in protein expression of downstream stream targets, and through
differences in FMRP-mRNA interactions in control and ethanol-treated
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hippocampal slices. Studies in this chapter addressed whether this increase in
FMRP phosphorylation is necessary for ethanol-induced homeostatic changes
NMDA receptors, Kv4.2, and KChIP3 protein expression, and whether blockade
of FMRP phosphorylation will prevent these changes. Studies characterizing
other disorders defined by hyperexcitability have shown that aberrant FMRP
function dysregulates both basal state and activity-dependent translation, and
that knockdown of FMRP in dissociated cultures corrects this phenotype (Jeon et
al 2012; Russo et al 2013; Takei and Hiroyki 2014). Consistent with this, results
presented here show that inhibition of FMRP phosphorylation can prevent
ethanol-induced changes in both mRNA trafficking and protein expression of the
GluN2B subunit and inhibitory proteins Kv4.2 and KChIP3. This suggests that
FMRP phosphorylation is not only an integral component of synaptic plasticity in
dendrites and dendritic spines, but that it is necessary for local activity-dependent
alterations in protein expression.
As with previous results, FMRP phosphorylation did not affect GluN1
protein expression or mRNA binding. These studies indicate that FMRP
phosphorylation at S499 is not required for ethanol-induced increases in GluN1
protein expression, and this is mediated by other activity-dependent mechanisms.
Studies examining fragile X syndrome and epilepsy suggest that K+- channel
deficits may contribute more to the hyperexcitable phenotype than NMDA
receptor deficits (Henry 2008; Mercaldo et al 2009; Gross et al 2011; Lee et al
2011). As such, in chronic ethanol exposure, FMRP may have a greater impact
on proteins that are mediators of glutamateric signaling in dendritic spines, rather
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than NMDA receptor expression directly. Other pathways implicated in alcohol
use disorders, such as ERK and MAPK, are also key regulators of GluN1, and
may have a greater influence on GluN1 translation (Perkinton et al 2002; Ivanov
et al 2006). Our results also revealed that FMRP appears to play a significant
role in modulating GluN2B subunit expression, suggesting that FMRP have a
more influential role in NMDA receptor function through regulation of NMDA
subunit expression rather than total protein expression of the receptor itself.
Further studies investigating both signaling pathways are necessary to discern
how NMDA receptors are regulated and trafficked during chronic ethanol
exposure.
An important finding in these studies is that ethanol-induced changes in
FMRP phosphorylation and activity are mediated by S6K1, and are likely part of
the mTORC1 pathway. Work from other labs have shown that S6K1
phosphorylation is increased following chronic ethanol exposure, and that this
change in phosphorylation is essential to produce the long-term cellular and
behavioral phenotype induced by heavy ethanol exposure (Nesta et al 2010;
Barak et al 2013; Sabino et al 2013) Phosphorylation at S499 is not completely
dependent on S6K1 in all activity-dependent mechanisms, and phosphorylation
at this site may also be regulated by other mTORC1 substrates. Previous studies
examining local dendritic protein translation have manipulated mTORC1 and
showed changes in FMRP, rather than altering S6K1 directly. Results presented
here implicate S6K1 specifically as the upstream regulator for activity-dependent
increases in ethanol-induced FMRP phosphorylation at S499. This provides
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insight into how ethanol may induce these activity-dependent changes in FMRP
and its binding partners.
Experiments in these studies used a pharmacological intervention directed
at the upstream kinase S6K1 to alter FMRP phosphorylation, rather than direct
manipulation of the FMRP protein. The S6K1 inhibitor PF-4706871 affected
some, but not all substrates in the translational pathway. It is important to note,
that certain key proteins necessary for translation, namely S6 and eIF4E, were
not altered by the dose used in these experiments. Additionally, other
mechanism may compensate for low S6K1 activity, such as S6K2 and other
kinases in the RSK family including p90 ribosomal proteins RSK1 & 2
(Urbanaska et al 2012). This inhibitor also did not interfere with the ability of
mTORC1 to phosphorylate S6K1, or any of the other downstream components,
rather its action appears to be limited to S6K1 (Pearce et al 2010). Limiting
inhibition to S6K1 was of particular importance for these sets of studies to ensure
proper assembly of the polyribosome and to preserve the ability of neurons to
induce activity-dependent translation.
Although fmr1-/- mice are available, the developmental phenotype that
includes important cellular changes in activity, differences in circuitry and
synaptic development, and the behavioral deficits in knockout animals as adults
makes them a difficult model system in the context of these experiments (Zhao et
al 2005; De Rubeis and Bagni 2011; Sidorov et al 2013). The goal of these
studies was to determine whether FMRP has a role in the homeostatic changes
at glutamatergic synapses using typical activity-dependent mechanisms. With the
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established cellular and behavioral phenotype, fmr1-/- mice do not have typical
activity-dependent translational mechanisms that include differences in basal
Kv4.2 protein levels, and hippocampal-dependent memory tasks, and are not as
useful for these studies (Gross et al 2011; Lee et al 2011; Darnell and Richter
2012).
FMRP and S6K1 have previously been shown to be important in regulating
hyperexcitability in the hippocampus (Hara et al 1998; Lenz and Avruch 2005;
Fenton and Gout 2011; Lee et al 2011). Studies in this chapter reveal that not
only is FMRP activity altered through S6K1-mediated phosphorylation in
response to chronic ethanol exposure, but also that this increase in
phosphorylation is necessary for ethanol-induced changes in translation.
Blockade of FMRP phosphorylation also prevented alterations in mRNA
trafficking and protein expression. In addition to differences protein translation,
alterations in S6K1 and FMRP-mediated signaling pathways have been shown to
alter spine morphology and actin polymerization (Calabrese et al 2006; Bongmba
et al 2011; Bowling and Klann 2014). Experiments in the next chapter will
address whether differences in spine morphology are linked to changes in protein
expression and drinking behaviors.
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Chapter 4

Ethanol-induced alterations in FMRP-mediated
translation are accompanied by changes in spine
morphology

Background and Significance

Data presented in the previous chapters focused on the role of ethanolinduced alterations in FMRP-mediated translation in the hippocampus of proteins
associated with homeostatic changes at glutamatergic synapses. However,
changes in protein expression are often accompanied by alterations in spine
morphology and actin polymerization (Fukazawa et al 2003; Kasai et al 2003;
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Lebeau et 2011; Chen et al 2014). Following chronic ethanol exposure, previous
studies have observed an increase in actin clusters and enlargement of dendritic
spines (Carpenter-Hyland and Chandler 2006; Zhou et al 2007; Brigman et al
2010). In a number of developmental disorders, dysregulation of translational
mechanisms results in alterations in dendritic spine shape and distribution
(Krueger and Bear 2011; Hoeffer et al 2012; De Rubeis et al 2013; Pathania et al
2014; Han et al 2015; Neuhofer et al 2015). In fragile X syndrome and fmr1-/animals, loss of FMRP resulted in an increase in spine density that is largely due
to an increase in stubby spines (Krueger and Bear 2011; Hoeffer et al 2012;
Neuhofer et al 2015).
Several mechanisms may regulate spine development and actin dynamics
in the hippocampus. Of interest to these studies is the WAVE complex protein
termed cytoplasmic FMRP interacting protein 2 (Cyfip2). As a binding partner of
FMRP as well as a member of an actin regulatory complex, Cyfip2 may serve as
a link between local activity-dependent translational changes and alterations in
spine morphology (Smith and Rong 2004; Zhao et al 2013; Abekhoukh and
Bardoni 2014). Fragile X patients exhibit an increase in Cyfip2 expression in the
hippocampus, and fmr1-/- animal models also show increased Cyfip2 expression
that accompanies the increase in immature stubby spines (Castets et al 2004;
Hoeffer et al 2012). Cyfip2 regulates actin polymerization through direct
interaction with the WAVE complex and inhibits WAVE activity and F-actin
formation (Smith and Rong 2004; Pilpel and Segal 2005; Zhao et al 2013; Chen
et al 2014). As illustrated in Figure 4-1, the binding of GTP-bound Rac1 to Cyfip2
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induces dissociation between WAVE and Cyfip2, allowing for disinhibition and an
active WAVE complex (Castets et al 2005; Zhao et al 2013; Chen et al 2014).
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Cyﬁp'
Nap'

Abi2'

Figure'441&&Cyﬁp20mediated&ac+n&polymeriza+on&

'
Cyﬁp2& directly& interacts& with& the& WAVE& complex& to& inhibit& ac+n&
polymeriza+on& and& spine& forma+on.& GTP0bound& Rac1& causes&
disassocia+on& between& cyﬁp2& and& WAVE& to& increase& f0ac+n.& & The&
unbinding& of& Rac1& allows& cyﬁp2& to& bind& WAVE& and& inhibit& ac+n&
polymeriza+on&

Recent work by Kumar et al 2013 demonstrated a potential role for Cyfip2 in
regulating the morphological and behavioral changes resulting from drug abuse.
In this study, a SNP polymorphism in the Cyfip2 gene of two substrains of
C57BL/6 mice were identified in which a serine found in the C57BL/6J mice was
substituted with a phenylalanine in the C57BL/6N mice (Kumar et al 2013) It was
further observed that this SNP is found in all commercially available mice of the
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6N substrain (Figure 4-2). This polymorphism codes for an unstable form of
Cyfip2, and it was hypothesized that this instability disrupts proper coordinated,
activity-dependent changes in spine morphology. Additionally, 6N animals were
shown to be resistant to acute cocaine-induced increases in locomotor
sensitization, displayed fewer active lever presses, and did not show
reinstatement. Spine analysis showed an overall decrease in density, and a
highly significant decrease in long/thin spines in the nucleus accumbens (Kumar
et al 2013).
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A"

B"

Figure"4*2!!Cyﬁp2!SNP!change!between!diﬀerent!C57BL/6!mouse!lines!
from*Kumar*et*al,*2014*
!

A."!Single!nucleo>de!subs>tu>on!in!the!C57BL/6N!mice!compared!to!6J.!B.!SNP!
does!not!alter!total!protein!expression,!but!is!less!stable!with!a!shorter!halfElife."

Studies presented in this chapter aim to discern whether ethanol-induced
alterations in local protein translation are accompanied by changes in spines
morphology. Using two commercially available substrains of C57BL/6J or /6NJ,
these experiments may provide insight into how chronic ethanol alters both
protein expression and spine morphology in an activity-dependent manner.

119

Methods

Animals
Animals used in these studies consisted of two different substrains of
C57BL/6 mice: C57BL/6J and C57BL/6NJ. Both lines were obtained from
Jackson Labs and will be referred to as 6J and 6N, respectively. Twenty-four
male mice per genotype (48 animals total) arrived at 9 weeks of age, and were
allowed to acclimate to the animal vivarium for 2 weeks. All animals were singly
housed on a 12 hour light/dark cycle. Lights were off from 11am -11pm. Animals
had access to food and water in the home cage throughout the entire experiment.
Cages were changed and animals weighed weekly at least 48 hours after the
end of the last 24-hour session. All experimental procedures were approved by
the Animal Care and Use Committee and the National Institutes of Health.

Two-bottle choice and chronic intermittent ethanol vapor exposure
For the two-bottle choice ethanol drinking procedure, mice were divided into
two treatment groups: a Naive group that received tap water in both bottles, and
an EtOH group that received one bottle containing 15% ethanol and another
bottle containing only tape water. Groups represented in the study are 6J Naive,
6N Naive, 6J EtOH, and 6N EtOH. Each bottle was assigned to a specific animal,
and bottles were cleaned and refilled between each session, and all bottles were
weighed before and after each session. Weight difference was converted to
volume using the contributing density of ethanol. Volume was then converted to
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grams per kilogram (g/kg). Mice gained and lost weight throughout both baseline
drinking and chamber weeks, and the average of weights before and after each
drinking week was used to calculate g/kg. Drinking sessions began 1 hour before
the dark cycle, with bottle weights taken after 4 and 24 hours. After 4 consecutive
24-hour drinking sessions, bottles were removed, and all animals were provided
home cage tap water for 72 hours.
Following four weeks of baseline two-bottle choice drinking, mice then
began the chronic intermittent ethanol vapor exposure paradigm. A member of Dr.
Howard Becker’s lab kindly performed the vapor chamber exposure for these
experiments. As illustrated in Figure 4-3, mice that received ethanol during the
two-bottle choice drinking sessions underwent ethanol vapor exposure for 16
hours followed by an 8 hour withdrawal as described previously in Becker and
Lopez 2004, Lopez and Becker 2005, and Griffin et al 2014.
The water only group received air exposure for the 16-hour period and
remained ethanol naive. Both groups received IP injections of pyrazole
(1mmol/kg) and an ethanol prime injection (1.6 g/kg; 8% w/v). This 16-hour vapor
session was followed by an 8-hour withdrawal period, and animals continued this
cycle for 4 consecutive days. This was followed by a 72-hour withdrawal period.
Blood was taken via retro-orbital bleed on either the 3rd or 4th day of each of the
cycles for determination of blood ethanol concentration (BECs). After each week
of ethanol exposure and withdrawal, mice began two-bottle choice drinking for 4
days, and then another 72-hour withdrawal period. These two week cycles were
repeated 4 consecutive times. Following the last day of two-bottle choice drinking
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after the fourth cycle of vapor exposure, mice were euthanized with urethane
(1.5g/kg) and were either perfused for spine analysis or brains were taken for
western blot analysis.
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withdrawal!period.!Brains!were!extracted!at!the!end!of!the!4th!week!of!two%bo'le!choice.!!

Diolistic labeling and spine analysis
Diolistic labeling of slices obtained from fixed brains was used to assess the
effects of CIE and active drinking on dendritic spine morphology in the
hippocampus as previously described (Kroener et al. 2012). In brief, 6 mice from
each of the 4 experimental groups were anesthetized and perfused with 0.1 M
phosphate buffer followed by 1.5% paraformaldehyde (PFA) in phosphate buffer
and post-fixed in 1.5% PFA for 1 hour at room temperature. Brains were then
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kept at 4oC in 0.1 M phosphate buffer until coronal sections of 150 µm were
prepared on a vibratome. Tungsten particles (1.7 µm diameter) coated with DiI
were delivered diolistically using a Helios Gene Gun (Bio-Rad) fitted with a
polycarbonate filter (3.0 µm pore size; BD Biosciences). DiI was allowed to
diffuse overnight at 4°C, and the slices were then post-fixed in 4% PFA for 1 hour
prior to mounting. Images of the apical dendrites of the CA1 region of the
hippocampus were collected in the Z-plane with a stack interval of 0.1 µm. A total
of 8 z-stack images of 6-8 dendrites from 8 different cells per animal were
collected. AutoQuant (MediaCybernetics, Rockville, MD) was then used to create
deconvolved 3-D images. A filament of the dendritic shaft and spines was then
created using Imaris XT (Bitplane, Zurich, Switzerland). Dendritic spines were
classified as long, mushroom, stubby, or filopodia based on their length and neck
and head width, where L is spine length, WH is spine head width, and WN is
spine neck width. Long spines were identified as having a L≥0.75 µm and <3 µm,
mushroom spines as a L<3.5 µm, WH>0.35 µm and a WH>WN, stubby spines
had a L<0.75 µm, and filopodia were identified as having a L≥3 µm.
Lysate preparation and protein assay
Six animals per group were euthanized and 1.0 mm coronal brains slices
were prepared using a standard brain block. From these slices, 2.0 mm bilateral
tissue punches of the hippocampus were homogenized by sonication in 4% LDS .
Protein concentration was determined by the BCA procedure described in
Chapter 2.
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Western blot analysis
Western blots were performed as described in Chapter 2. Briefly, following
electrophoresis and membrane transfer, a reversible Swift total protein stain was
used to evaluate errors in loading and normalization. Following the total protein
stain, membranes were blocked in 4% non-fat milk, and incubated in primary
antibody at 4oC overnight. Primary antibodies included phospho-S499 S499
FMRP (1:1000), FMRP total protein (1:2000), KChIP3 (1:500), Kv4.2 (1:1000),
GluN1 (1:3000), and GluN2B (1:3000). After primary antibody incubation,
membranes were incubated in secondary antibody: S499 FMRP, FMRP, and
KChIP3 with goat anti-rabbit (1:2000) Kv4.2, GluN1, and GluN2B with goat antimouse (1:2000), for 1 hour at room temperature. After secondary antibody
incubation, membranes were exposed to an enhanced chemillumiscience with
ChemicDoc MP Imaging System (Bio-Rad, Hercules, CA).

Statistical Analysis
Two-bottle choice drinking data was analyzed using SPSS (IBM) with either
a one- or two-way repeated measures ANOVA (* p< 0.05). Significance for
animal weights was examined using student t-test, and the spine data were
analyzed with SPSS using a general linear mixed model. Western blots were
analyzed with a one-way ANOVA in GraphPad Prism.
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Results

Blood Ethanol Concentrations (BECs)

Following baseline two-bottle choice drinking, mice were exposed to four
cycles of vapor exposure along with a two-bottle choice 24-hour access
paradigm between each week of vapor exposure. As seen in Figure 4-4, bloodethanol levels steadily rose for both groups with each chamber cycle. While the
reason for this increase is not clear, no significant differences were found
between 6J and 6N animals throughout any cycle (one-way ANOVA, F(3,66) =
0.2964, p> 0.05 n= 12).
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Figure'4)4'''Average'BEC*measurements*for*each*ethanol*vapor*exposure*cycle.*
*
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cycle*show*no*diﬀerence*in*BECs*between*6J*and*6N*animals*(n=*6**p*>0.05).*
Genotype'

Cycle'1'

Cycle'2'

Cycle'3'

Cycle'4'

6J'
'

123.5**±**7.48*

167.2**±**7.00*

218.3**±**13.67*

242.7**±*12.83*

6N'
'

119.7**±**4.86*

145.3**±**7.70*

214.0**±**19.29*

229.7**±**18.83*

'
Table'4)1.*BECs*for*each*chamber*cycle*(average*±*SEM)'

Two-bottle choice 24-hour access

During two-bottle choice drinking, animals were divided into four groups
with 6 animals per group as follows: 6J Naive- water only, 6J EtOH- ethanol and
water, 6N Naive- water only, and 6N EtOH- ethanol and water. Mice were given
free access to bottles for 24 hrs with time points taken after 4- and 24-hours
during the two-bottle choice paradigm. Throughout the baseline period and most
of the drinking days between ethanol vapor exposures, mice in the 6J EtOH
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group exhibited significantly higher ethanol intake (g/kg) in a 24-hour period
compared to the 6N EtOH group (Figure 4-5A, two-way ANOVA, F(31, 682)=
1.928 p= 0.0020, Sidak post-hoc, * p< 0.05, n= 12, 11). 6N and 6J groups also
differed in their total daily water consumption. Not only did 6N mice consume less
ethanol overall, they also consumed more water compared to 6J ethanol-drinking
mice (Figure 4-5B, two-way ANOVA, F(31, 682)= 2.811 p= 0.0016, Sidak posthoc, * p< 0.05, n= 12, 11). Additionally, although 6N mice consumed less ethanol
compared to the 6J group, both 6J and 6N mice exhibited an escalation in
drinking following the final week of vapor exposure compared to their respective
baseline levels (Figure 4-5C, two-way ANOVA; F(4,15)=5.085; p= 0.0163; Tukey
post-hoc * p< 0.05, n= 12, 11). Therefore, both genotypes showed CIE-induced
escalation in ethanol consumption. However, these two sub-strains varied in
baseline overall ethanol intake. Total water intake for the ethanol-naïve 6J and
6N mice did not significantly vary by genotype. (Figure 4-6, two-way ANOVA,
F(31, 682)= 1.286 p= 0.1390, n= 12).
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The difference in water consumption between the 6J and 6N genotypes
resulted in significantly lower total fluid intake over several 24-hour sessions for
the 6J ethanol-drinking mice compared to 6N ethanol animals (Figure 4-7A, twoway ANOVA, F(31, 682)= 3.040 p= 0.0030, Sidak post-hoc, * p< 0.05, n= 12, 11).
Interestingly during two-bottle choice drinking between chamber exposures as 6J
mice increased their ethanol intake, their water consumption decreased. Ethanol
also accounted for a higher percent of total intake throughout most of the twobottle choice drinking paradigm (Figure 4-7B/C, B: two-way ANOVA, F(31, 682)=
2.820 p< 0.0001, Sidak post-hoc, * p< 0.05, n= 12, 11; C: two-way ANOVA, F(31,
682)= 3.438 p< 0.0001, Sidak post-hoc, * p< 0.05, n= 12, 11). However, the 6N
group maintained their water intake throughout the entirety of the paradigm.
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Although 6J mice consumed more ethanol throughout most of the 24-hour
drinking sessions, these studies also examined fluid consumption during the first
four hours of each these 24-hour drinking days (Figure 4-8, EtOH: two-way
ANOVA, F(31, 682)= 2.123 p= 0.0023, Sidak post-hoc, * p< 0.05, n= 12, 11;
Water: two-way ANOVA, F(31, 682)= 7.768 p< 0.0001, Sidak post-hoc, * p< 0.05,
n= 12, 11). After 4 hours of two-bottle choice, the 6J group had significantly
higher ethanol consumption for most of the baseline drinking phase compared to
6N mice. However, following chamber exposure periods, 6J and 6N animals
maintained similar levels of ethanol intake for the first four hours on most drinking
days. As expected, 6N animals had significantly higher water intake compared to
6J mice throughout the entirety of the paradigm. Additionally, following chamber
exposure, as 6N mice increased their intake of ethanol, water consumption also
increased, a trend that continued throughout the next 20 hours. In general, 6N
mice consumed less ethanol and more water than 6J animals. However, unlike
the four hours of drinking, there was no escalation in water consumption among
the 6N group (Figure 4-9, EtOH: two-way ANOVA, F(31, 682)= 2.144 p= 0.0004,
Sidak post-hoc, * p< 0.05, n= 12, 11; Water: two-way ANOVA, F(31, 682)= 2.580
p< 0.0001, Sidak post-hoc, * p< 0.05, n= 12, 11). Ethanol consumption also
remained relatively consistent throughout most of the paradigm for the last 20hour period. As noted above, due to this increase in water consumption during
the first four hours of the drinking sessions, total liquid intake increased in 6N
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animals, especially during each bottle week following vapor chamber exposures.
6J ethanol mice, however, remained relatively consistent during this time period.
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Throughout two-bottle choice drinking and CIE vapor exposure cycles, body
weight for all mice was recorded immediately before and after each cycle. It was
observed that both 6N naive and 6N ethanol groups lost weight following each
CIE vapor exposure, but gained weight during each two-bottle choice week.
Unlike the 6N genotype, minimal fluctuation in weight was observed for the first
three cycles of CIE vapor and two-bottle choice drinking in both 6J naive and 6J
ethanol mice. Following the fourth and final CIE chamber cycle, however, a
decrease of 4-5 grams was observed in both 6J and 6N ethanol mice. Mice in the
6J group had regained this weight at the time of sacrifice following the final twobottle choice drinking period. However, 6N ethanol mice did not experience any
weight gain at the time of sacrifice (Figure 4-10).
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Changes in protein expression in 6J and 6N mice following chronic ethanol
exposure

Data presented in previous chapters of this dissertation have shown that
chronic ethanol exposure alters expression of proteins associated with
homeostatic plasticity in the hippocampus in both a CIE in vivo mouse model and
in vitro hippocampal slice culture model. In the present chapter, hippocampal
tissue from 6J and 6N naive and ethanol-exposed mice were analyzed using
western blot for FMRP and other proteins of interest previously shown to be
altered by chronic ethanol. Expression of the translational repressor protein
FMRP

was

assessed

for

total

protein

and

the

previously

identified

phosphorylation site of interest (S499). Consistent with results from previous
chapters, blots revealed an increase in phospho-FMRP protein expression in
ethanol-exposed 6J mice compared to 6J naive animals. Additionally, the 6J
ethanol group exhibited an increase in phosphorylated FMRP compared to both
6N treatment groups. Importantly, the 6N ethanol mice did not show an increase
in expression of either phosphorylated or total FMRP protein expression
compared to either the 6J or 6N naive groups. As seen in previous studies, total
FMRP protein expression did not vary between any of the groups tested (Figure
4-11; phospho-FMRP: one-way ANOVA, F(3,20) = 5.152, p=0.0084, Tukey posthoc * p< 0.05 n= 6; FMRP: one-way ANOVA, F(3,20)= 0.1105, p=0.9528, Tukey
post-hoc p> 0.05 n= 6). Of note, these data also show no difference between the
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6J and 6N naive mice, indicating that the polymorphism in Cyfip2 does not lead
to differences in basal levels of phosphorylated or total FMRP protein.
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A."Ethanol.caused.the.expected.increase.in.FMRP.phosphoryla8on.in.6J.animals..This.diﬀerence.was.signiﬁcant.
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.
6J"Naive=.C57BL/6J.water/air.only,..6N"Naive=.C57BL/6NJ.water/air.only,..6J"EtOH"=.C57BL/6J.ethanol.treated,..6N"
EtOH=.C57BL/6NJ.ethanol.treated."
.

In the next set of experiments, NMDA receptor subunits were evaluated in
both genotypes. As observed in Chapter 2, 6J mice exposed to chronic ethanol
displayed increased levels of GluN1 protein expression compared to 6J ethanol
naive animals (Figure 4-12; GluN1: one-way ANOVA, F(3,19) = 6.733, p=0.034,
Tukey post-hoc * p< 0.05 n= 5, 6; GluN2B: one-way ANOVA, F(3,20) = 5.844,
p=0.0049, Tukey post-hoc * p< 0.05 n= 6). Additionally, the 6J ethanol group also
showed increases in GluN1 compared to 6N naive mice. There was a slight, nonsignficant increase in GluN1 in the 6N ethanol group. GluN2B protein levels were
increased with 6J ethanol mice compared to both the 6J and 6N naive group.
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However, 6N ethanol-exposed mice did not show any increase in GluN2B levels
compared to either control group. Genotypic differences between the two naive
groups did not result in any change with either GluN1 or GluN2B protein levels.
Like FMRP, this indicates there is no difference in basal expression of either
protein.

6J?n( 6N?n( 6J?e( 6N?e(

6J?n( 6N?n( 6J?e( 6N?e(

GluN1'
*(

*(

Relative Density

60
40
20
0

B'

150

*(
(total protein)

100
80

(total protein)

Relative Density

A'

GluN2B'

100

50

0

6J Naive 6N Naive 6J EtOH 6N EtOH

Treatment

*(
*(

6J Naive 6N Naive 6J EtOH 6N EtOH

Treatment

Figure'4)12'Increases(in(NMDA(receptor(subunits(following(ethanol(exposure(in(6J,(but(not(6N(mice.(
'

A.'An(exposure(paradigm(of(two?bo@le(choice(with(alternaAng(vapor(chamber(exposures(induced(the(expected(
increases(in(6J(mice(compared(to(both(6J(and(6N(ethanol(naive(animals(((n=(6,(*(p<(0.05).((B.'Ethanol(also(increased(

GluN2B(subunit(expression(in(6J(animals(compared(to(both(ethanol(naive(groups.(However,(this(was(also(signiﬁcantly(
diﬀerent(from(6N(ethanol(exposed(animals(
(
6J'Naive=(C57BL/6J(water/air(only,((6N'Naive=(C57BL/6NJ(water/air(only,((6J'EtOH'=(C57BL/6J(ethanol(treated,((6N'
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In addition to NMDA receptor subunits, Kv4.2 and KChIP3 protein levels
were also assessed in both mouse lines (Figure 4-13; Kv4.2: one-way ANOVA,
F(3,19) = 5.122, p=0.0104, Tukey post-hoc * p< 0.05 n= 6, 5; KChIP3: one-way
ANOVA, F(3,20) = 6.248, p=0.0047, Tukey post-hoc * p< 0.05 n= 6). This
analysis revealed both Kv4.2 and KChIP3 expression was decreased as a result
of ethanol exposure in the 6J mice compared to both 6N and 6J ethanol naive
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mice. However, protein levels in 6N ethanol-treated mice remained unchanged
compared to both naive groups. Data also show no change between 6J or 6N
naive mice. These observations also indicate no baseline differences in
expression of these proteins between the two genotypes for either protein.
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Spine morphology in 6J and 6N naive and ethanol-treated mice

It has been previously reported that Cyfip2 function is associated with a
reduction in overall spine density in the nucleus accumbens that was largely due
to a decrease in thin and stubby spine density (Kumar et al 2013). This decrease
in spine density was accompanied by a resistance to cocaine-induced locomotor
sensitization and decreased cocaine-seeking behaviors. Previous studies have
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also shown that ethanol-induced changes in actin polymerization result in
enlargement of dendritic spines, and this enlargement may be dependent on
changes in protein expression (Carpenter-Hyland and Chandler 2006; Zhou et al
2007; Cingolani and Goda 2008; Akashi et al 2009). Therefore, the next set of
studies examined the effect of ethanol exposure in hippocampal dendritic spine
density and morphology between the 6J and 6N mouse lines.
Quantification of the spine density in the CA1 region of the hippocampus
yielded results similar to previous finding in the nucleus accumbens (Kumar et al
2013). 6N ethanol naive mice showed baseline differences in spine density
compared to the 6J naive group. Exposure to chronic intermittent ethanol caused
an increase in total spine density of 6J mice compared to both 6J and 6N naive
groups as well as 6N ethanol-exposed animals (Figure 4-14; Total spines:
F(2,18)= 5.156, * p <0.05, n= 6, 5; Classification of spines: F(3,85)= 2.254, * p<
0.05, n= 6, 5). Classification of dendritic spines revealed that these alterations in
total density were due specifically to changes in long/thin spines. Compared to 6J
naive mice, the 6N naive group showed a significant decrease in long/thin spines,
suggesting baseline differences in spine density and morphology between the
two genotypes. Mice in the 6J ethanol group exhibited an increase in density
compared to 6J naive mice, and this increase was also characterized by
increased density of long/thin spines.
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Discussion

The results of studies in this chapter revealed two important findings. The
first that alterations in Cyfip2 function may correlate to a reduction ethanol
consumption. However, the 6N mice carrying the phenylalanine SNP still
exhibited CIE-induced escalation in drinking. Secondly, 6N animals do not show
baseline differences in proteins implicated in synaptic plasticity, but do not induce
mechanisms that allow for homeostatic changes in protein expression and spine
morphology. Additionally, similar to previous results reported in the nucleus
accumbens, 6N naive mice have baseline differences in spine density and
morphology compared to the 6J strain in hippocampal CA1 pyramidal neurons
(Kumar et al 2013)
These results further suggest that the polymorphism in the cyfip2 gene that
alters protein stability may have a significant influence over synaptic plasticity in
not only spine morphology, but also protein translation and drinking behaviors.
Not only did 6N ethanol-exposed animals drink less ethanol, they also consumed
more water, and this water intake increased as ethanol consumption increased.
Both 6J and 6N animals consumed more ethanol in the first four hour period than
the expected daily intake, assuming a constant rate of consumption over 24
hours. 6N ethanol treated animals consumed more in the first four hours,
indicating they drink more at the start of the dark cycle, but do not maintain this
behavior throughout the 24-hour period. The drop off in consumption seen during
the last 20 hours of the session is not likely a result of decreased ethanol
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metabolism since BECs did not differ between the two genotypes following CIE
exposure. Also, 6N animals did show escalation in drinking during two-bottle
choice weeks following the final two weeks of chamber exposure, but did not
escalate to the levels achieved by 6J mice. Of note, the 6J animals drinking
levels were relatively even throughout the first four hours during both baseline
and chamber periods, suggesting that the escalation in drinking did not occur
during the first part of the dark cycle, but 6N animals displayed the opposite
behavior, increasing ethanol consumption in the first 4 hours.
As with previous chapters, differences in protein expression was also
evaluated in naive and ethanol-exposed animals. In mice, decreased Cyfip2 total
protein expression has been shown to cause a reduction in basal levels of FMRP
total protein as well as cognitive deficits similar to fmr1-/-. However, 6N naive
mice that show decreased Cyfip2 activity did not exhibit baseline differences in
FMRP phosphorylation or total expression, nor did they display any alterations in
GluN1, GluN2B, Kv4.2,or KChIP3 expression compared to 6J naive mice.
Additionally, ethanol treatment in the 6N group did not induce changes in protein
expression. However, the expected increases or decrease in GluN1 and GluN2B
or Kv4.2 and KChIP3, respectively, were observed in 6J ethanol mice compared
to 6J naive. This suggests that differences in Cyfip2 activity do not affect basal
protein expression, but may have an important role in activity-dependent
changes in FMRP activity and protein translation. However, further experiments
are necessary to investigate the mechanism by which chronic ethanol mediates
both Cyfip2 and FMRP in response to alterations in homeostatic plasticity.
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The studies investigating structural differences in dendritic spines revealed
that 6N mice exhibit a lower density of spines in the hippocampus compared to
6J mice. Analysis of spine type indicated this difference was largely due to a
decrease in the density of long/thin spines. This reduction in total density and thin
spines is similar to results from studies in the nucleus accumbens (Kumar et al
2013). Ethanol did cause a slight difference in 6N mice, but this did not vary
significant from either 6J or 6N naive mice. Again, this difference is due to an
alteration in long, thin spines. However, baseline differences in spine density and
morphology in the 6N naive mice were not accompanied by alterations in basal
protein levels. The 6N group was resistant to ethanol-induced changes in protein
expression and spine morphology. This suggests that changes protein translation
and actin polymerization that occur in tandem may be limited to activitydependent plasticity, and that basal protein translation and actin dynamics may
be differentially regulated.
Drinking studies in this chapter indicate 6N mice with the polymorphism in
cyifp2 consumed less ethanol that 6J mice. Although 6N mice did escalate their
ethanol intake compared to baseline, consumption in the 6N ethanol group was
still significantly less than 6J animals for several 24-hour time points. Studies with
cocaine with a knock-in of the 6N SNP on a 6J background produced the same
cellular and behavioral phenotype as the commercially available 6N mouse lines,
suggesting that Cyfip2 activity has an important role in drug-induced behaviors.
However, further studies are needed to determine how the polymorphism found
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in 6N animals behavioral differences seen in response to chronic ethanol
exposure.
A potential confound in these chronic intermittent ethanol studies was
the observation that weight in both groups of 6N mice fluctuated throughout each
cycle of CIE vapor and two-bottle choice following the first four weeks of baseline
drinking. It is important to note that during the fourth and final chamber exposure,
both animals experienced higher than expected blood ethanol levels. Following
this vapor exposure cycle, mice in both 6J and 6N ethanol groups lost an
average of 4-5 grams in weight. The 6J mice gained all of the lost weight back by
the time of sacrifice; 6N mice, however, did not. This may have important
implications for actin dynamics and spine morphology. Alterations in body weight
are associated with either an increase or decrease in spine density, depending
on brain region (Stranahan et al 2008; Stranahan et al 2009; Fan et al 2015). A
reduction in spine density was observed in the 6N naive group. However, these
data are consistent with previously published studies, showing this same
decrease in the nucleus accumbens. 6N ethanol-treated mice showed a slight
increase in spine density compared to the 6N naive group. It is difficult to
speculate whether this sudden change in body weight contributed to the
behavioral and cellular phenotype.
Results presented in this chapter reveal the importance of homeostatic
mechanism in dendrites and dendritic spines for regulating protein expression,
spine morphology, and drinking behaviors. With the polymorphism in Cyfip2 in
6N animals, failure to induce appropriate mechanisms to maintain the necessary
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activity-dependent changes in protein expression and actin polymerization in
order to adapt to chronic ethanol exposure produced not only differences in
baseline drinking, but also changes in escalation. Although there is no baseline
difference in protein expression, as seen with spine density, this indicates that
basal state protein expression may be regulated in a different manner. However,
activity-dependent mechanisms may require the ability to change both protein
expression and actin polymerization to reestablish homeostasis.
Studies in this chapter addressed whether changes in protein expression
are also accompanied by changes spine morphology. The naturally occuring
polymorphism in the cyfip2 gene between the -J and -N substrains of C57BL/6
provides the opportunity to address how differences in spine morphology may
affect both baseline and ethanol-induced activity-dependent dendritic protein
synthesis. Further studies are needed to determine the nature of the connection
between protein translation and spine morphology, and how these two processes
may alter drinking behaviors.
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Chapter 5

Discussion and Future Directions

Translational Changes and Plasticity

Synaptic plasticity is an essential process that allows for homeostatic
neuronal adaptations in response to changes in the cellular environment in order
to maintain balanced homeostatic function. Plasticity in the hippocampus is
necessary for alterations in synaptic activity that have important implications for
hippocampal

function,

including

memory
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processing

and

consolidation

(Grosshans et al 2001; Fukazawa et al 2003; Hoeffer et al 2013; Bailey et al
2015). Long-term maintenance of these adaptations requires alterations in
protein homeostasis and translation of new proteins (Kang et al 1996; Klann and
Richter 2007; Im et al 2009; Panja et al 2014). Cellular processes previously
investigated that regulate activity-dependent protein synthesis have focused on
transcription and somatic translation. However, more recent studies have
demonstrated that maintenance of synaptic plasticity also requires alterations in
local dendritic translation (Kang et al 1996; Klann and Richter 2007; LiuYesucevitz et al 2011). Activity-dependent de novo protein synthesis requires a
series of highly coordinated synaptic events that are tightly regulated at each
step. Pathologies, such as fragile X syndrome, that are characterized by aberrant
translational regulation leads to alterations in basal protein levels and deficits in
maintaining synaptic plasticity (Li et al 2001; Hagerman and Stafstorm 2009;
Darnell et al 2011; De Rubeis and Bagni 2011; Henry 2011). This insufficient
regulation of translation is accompanied by cognitive deficits and developmental
delays, and the investigation of the how these components are precisely
regulated remains an active area of research.
Previous studies have identified the mTORC1 translational pathway as one
of the main cellular mechanism regulating activity-dependent translation in
dendrites. The sensitivity of synaptic plasticity and memory consolidation to
inhibition of mTORC1 implies that coordinated activity of mTORC1 substrates is
likely necessary for maintenance of homeostasis (Gong et al 2006; Bekinschtein
et al 2007; Meng et al 2013; Russo et al 2013; Takei and Hiroyki 2014; Dibble
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and Cantley 2015). In response to chronic ethanol exposure, studies with in vivo
rat models revealed an increase in several downstream components as well as
alterations in protein expression at glutamatergic synapses and in dendritic
spines (Nesta et al 2010; Barack et al 2013; Nesta et al 2014). Components of
this pathway include kinases, mRNA-binding proteins, and ribosomal subunits
that control mRNA trafficking and stability, assembly of the active ribosome, and
the rate of translation. Different substrates in this pathway are discretely
activated to fine-tune protein synthesis that is necessary for alterations in
synaptic activity (Ma and Blenis 2009; Urbanska et al 2012; Meng et al 2013;
Takei and Hiroyki 2014). However, how the different proteins in the mTORC1
pathway are tightly regulated is not known.
Studies examining mTORC1 signaling following chronic ethanol exposure
have demonstrated that this signaling pathway and its substrates have an
important role in maintaining ethanol-induced alterations in protein expression
(Nesta et al 2010; Barak et al 2013; Sabino et al 2013). Studies in this
dissertation revealed that ethanol-induced alterations in expression of proteins
that are key mediators of neuronal excitability in dendrites and dendritic spines
may also be regulated by mTORC1 pathway. Results in these experiments from
both in vivo and in vitro studies show that chronic exposure to ethanol causes an
increase in GluN1 and GluN2B subunit expression in the hippocampus but a
reduction in Kv4.2 and KChIP3 protein levels. Together, these changes in protein
expression may tip the equilibrium in cellular signaling toward excitability to
reestablish neuronal homeostasis during chronic ethanol exposure. These
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studies also provide evidence that FMRP, a downstream substrate in the
mTORC1 pathway, may be an important mediator of alterations in NMDA
receptor, Kv4.2, and KChIP3 protein expression. As an mRNA-binding protein,
FMRP interacts with a variety of different mRNAs to inhibit their translation
(Laggerbauer et al 2001; Jones 2003). Although FMRP is a translational
repressor, its activity is necessary for maintenance of basal protein synthesis and
activity-dependent translation in dendrites and dendritic spines (Zalfa et al 2006;
Henry 2011; Schaeffer et al 2012). In the absence of FMRP, local dendritic
translation is uncoordinated, leading to disorganization of translation with no de
novo synthesis of the specific proteins that are required to maintained synaptic
plasticity.

FMRP and Ethanol Exposure

Ethanol-induced changes in FMRP and its binding partners

Studies investigating alterations in synaptic plasticity in response to ethanol
exposure have identified a role for protein translation in maintaining neuronal
homeostasis (Nesta et al 2011; Barak et al 2013). Studies presented here
revealed that not only does chronic ethanol exposure induce alterations in
proteins that modulate synaptic activity, but they also provide insight into how
ethanol may induce these changes in protein levels. Results from Chapter 2
demonstrated an increase in FMRP phosphorylation following exposure to acute
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and chronic ethanol with no change in expression. Additional experiments also
showed alterations in FMRP-mRNA interactions in ethanol-treated slice cultures
compared to control cultures. Studies in Chapter 3 then demonstrate that
blockade of ethanol-induced increases in FMRP phosphorylation through
inhibition of S6K1 activity prevent alterations in GluN2B, Kv4.2, and KChIP3 in
response to chronic ethanol exposure. These observations suggest that ethanol
exposure not only increases FMRP activity, but also alters FMRP-mRNA
interactions.
Findings presented in Chapters 2 and 3 provide support to the suggestion
that FMRP is an essential component of synaptic homeostasis during ethanol
exposure, and that FMRP is necessary for coordinated activity-dependent
translation in response to ethanol exposure. Previous studies have focused on
mTORC1 as a global regulator of activity-dependent translation (Gong et al 2006;
Nesta et al 2010; Barak et al 2013; Brewster et al 2013). In contrast, this
dissertation provides insight into the role of a specific mTORC1 substrate in
discrete regulation of proteins altered by chronic ethanol exposure.
It is important to note that inhibition of FMRP activity prevented ethanolinduced increases in GluN2B, but not GluN1 protein expression. This suggests
that FMRP activity does not have a critical role in regulating overall increases in
NMDA receptor protein expression. Rather FMRP may indirectly influence NMDA
receptor function or localization through regulation of receptor subunit
composition.
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Another implication of these FMRP experiments is that these studies
focused on FMRP in a typically developing brain. Research examining the role of
FMRP in synaptic plasticity often utilize clinical populations with aberrant FMRP
function, as seen in fragile X syndrome, or mouse models that lack the FMRP
protein (Gross et al 2011; Lee et al 2011; Jeon et al 2012; Hoeffer et al 2013.
Although these types of studies have provide important insight into the
irregularities in cellular structure and function related to the loss of FMRP, there
is little research in model systems with typical FMRP protein expression.
Experiments in this dissertation focused on the role of FMRP in activitydependent protein synthesis when FMRP expression is regulated via normal
cellular processes. Results from these studies may contribute to the
understanding of basic FMRP function in dendritic translation.

S6K1-mediated FMRP activity during chronic ethanol exposure

FMRP is part of a larger mTORC1 signaling pathway that mediates activitydependent translation (Holz et al 2005; Ma and Blenis 2009; Russo et al 2013).
This pathway includes numerous downstream kinases that activate different
components for proper coordination of translation. In vitro studies in Chapter 3
demonstrated that both increased FMRP phosphorylation at S499 and alterations
in FMRP-mRNA binding are regulated by S6K1 activity. Experiments in a rat
model

of

chronic

exposure

also

demonstrated

an

increase

in

S6K1

phosphorylation as well as an increase in protein expression for other mRNAs
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that are downstream substrates of FMRP (Nesta et al 2010; Barak et al 2013;
Nesta et al 2014). Importantly, decreased S6K1 activity in vivo has been shown
to prevent ethanol-seeking behaviors and ethanol-induced increases in protein
expression (Barak et al 2013). Taken together, these results suggest that FMRP
phosphorylation and activity are likely mediated by S6K1 during ethanol
exposure.
FMRP contains multiple binding sites for mRNAs and regulatory proteins,
and its activity can be regulated through different cellular pathways. S6K1mediated phosphorylation of S499 on FMRP provides important insight into how
FMRP activity is regulated during ethanol exposure (Bardoni et al 1997; Brown et
al 1995; Jones 2003; Bartley et al 2014). Phosphorylation at each of its three
serine residues differentially regulates activity to induce binding to 4E-BPs and
the ribosome to suppress translation, interaction with mRNAs, or interaction with
miRNAs that inhibit FMRP function (Bardoni et al 1997; Li et al 2001; Jones
2003; Chen and Joseph 2015). Regulation of FMRP through S6K1 suggests a
potential mechanism by which neurons maintain protein homeostasis during
chronic ethanol exposure.
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Spine morphology and activity-dependent translation

Regulation of WAVE through Cyfip2 activity

Long-term maintenance of protein homeostasis in dendrites is often
accompanied by alterations in actin polymerization and spine morphology. As
with protein translation, actin polymerization is a dynamic process that involves
several discretely coordinated components. Regulation of F-actin formation
through the WAVE complex is mediated through Cyfip2. Interaction between
Cyfip2 and WAVE prevents actin polymerization, while Rac1-dependent
activation of Cyfip2 induces disassociation from the complex (Miki et al 1998;
Zhao et al 2003; Bongmba et al 2011; Bellot et al 2014). This disassociation of
Cyfip2 from WAVE allows for disinhibition of the complex and active actin
polymerization (Smith and Rong 2004; Pilpel et al 2005; Kim et al 2006).
Decreased expression of Cyfip2 leads to dysregulated actin dynamics and an
increase in immature dendritic spines (Hoeffer et al 2013; Bellot et al 2014).
Additionally, this decrease in Cyfip2 is also correlated with an alteration in basal
protein levels (Napoli et al 2008; Panthania et al 2014; Han et al 2015). Likewise,
individuals with fragile X syndrome who lack FMRP and exhibit aberrant basal
and activity-dependent protein expression, also have increases in Cyfip2 (Hoeffer
et al 2013). This presents the possibility that chronic ethanol-induced alterations
in protein expression may be connected to ethanol-induced differences in spine
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morphology, and that FMRP and Cyfip2 both have an essential role in this
process.
As shown in Chapter 4, C57BL/6N mice (6N) with a polymorphism
substituting a phenylalanine in place of a serine residue in the cyfip2 gene
exhibited a decrease in spine density characterized by a decrease in long/thin
spines compared to C57BL/6J mice (6J). Exposure to chronic ethanol resulted in
an increase in spine density in 6J mice but not 6N mice. Of note, this SNP does
not affect the levels of Cyfip2 protein, but rather it decreases the half-life of the
protein and likely an increase in Cyfip2 turnover (Kumar et al 2013). This
increase in Cyfip2 turnover may interfere with discrete regulation of the WAVE
complex. While Cyfip2 is an inhibitor of WAVE activity, this inhibition may be
necessary to properly coordinate the different components needed for adaptive
cytoskeletal remodeling. Without this coordination, actin dynamics may remain
unregulated and unresponsive to alterations in synaptic activity.
Results from experiments in Chapter 4 suggest a connection between the
regulation of spine morphology and activity-dependent protein translation.
Although 6N mice had a reduced spine density, there was no difference in basal
protein levels compared to the 6J mice. However, unlike 6J mice, the 6N group
did not display ethanol-induced alterations in protein expression or FMRP
phosphorylation. One potential interpretation of these data are that protein
expression and spine morphology may be differentially regulated under basal
conditions, but both processes must occur in tandem to develop sustained
homeostatic adaptations to alterations in neuronal activity.
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Importance of Cyfip2 and FMRP during ethanol consumption

Alterations in both protein expression and spine morphology in response to
chronic ethanol exposure suggest that both of these processes are important for
maintaining neuronal homeostasis in response to changes in synaptic plasticity.
Data presented in Chapter 4 indicates that for activity-dependent adaptations to
occur, both changes in spine morphology and protein synthesis are necessary.
Results from these studies and others indicate that inhibition of either of these
two mechanisms prevents ethanol-induced cellular changes. Additionally, these
cellular changes may also influence behavioral phenotypes. As shown in Chapter
4, 6N mice consumed less ethanol compared to 6J mice in a long-term CIE/twobottle choice drinking paradigm. Although other factors may contribute to this
difference in consumption, when these drinking data are considered with activitydependent differences in protein expression and spine morphology, these data
suggest that Cyfip2 function may have an important role in the development of
drinking behaviors. These results also present the idea that the ability of neurons
to induce specific homeostatic mechanisms is directly connected to the
development of ethanol drinking and dependence. If 6N mice cannot initiate the
appropriate mechanism to adapt to ethanol-induced alterations in homeostasis,
does this contribute to the decreased ethanol intake? Conversely, are 6J mice
more susceptible to acquiring high ethanol drinking behaviors because they can
induce this specific homeostatic mechanism?
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Future Directions

This project outlines some important findings regarding how ethanol may
induce alterations in protein expression and spine morphology. Future studies to
further investigate how homeostatic protein translation is mediated in ethanol
exposure are needed. Results in Chapter 2 indicate that although protein
expression in dendrites did not change after acute ethanol exposure, FMRP
phosphorylation was increased after only 24 hours of ethanol treatment. Followup experiments could focus on FMRP activity during this period. FMRP can
regulate translation through several different means including interaction with the
active ribosome or other mRNAs that encode proteins needed for short-term
adaptations to ethanol. As a key mediator of 5’ TOP mRNAs, alterations in FMRP
activity may also be important for translation of proteins that make up the active
ribosome along with other mRNA binding proteins and key translational
regulators (Jefferies et al 1997; Darnell et al 2013). As a result of this increase in
phosphorylation, FMRP may have a significant role in mediating the transition in
neuronal homeostasis that occurs during the shift from acute to chronic ethanol
exposure.
An important direction for these future studies could focus on the questions
presented above. For example, are specific cellular homeostatic mechanisms
directly connected to drinking behavior, and how might activity-dependent protein
translation and actin dynamics be regulated? Cyfip2 is also mediated by
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upstream of Rac1 by S6K1 (Miki et al 1998; Castets et al 2005; Tolias et al 2005).
Therefore, S6K1 may serve as the common element of each mechanism
regulating both spine morphology and protein translation (Figure 5-1). Research
in non-neuronal cell types indicate that inhibition of S6K1 decreases interactions
between GTP-bound Rac1 and Cyfip, as well as preventing Cyfip2-mediated
cytoskeletal remodeling (Castets et al 2005). These studies also demonstrate
that Cyfip2-mediated actin dynamics are dependent on another downstream
substrate of S6K1, specifically, the Rac1 GEF Tiam1 (Castets et al 2005; Tolias
et al 2005). As with S6K1 inhibition, blockade of Tiam1 activity prevented
cytoskeletal alterations due to Cyfip2 activity (Castets et al 2005).

Future

experiments may also investigate these mechanisms in other brain regions
implicated in alcohol addiction and ethanol-induced cognitive deficits. Both the
S6K1 inhibitor used in these studies as well as a Tiam1-specific inhibitor are
commercially available.
Studies comparing the behavioral and cellular phenotype of C57BL/6J to 6N mice would build upon the body of work presented here. 6N mice consumed
less ethanol compared to 6J mice, but like the 6J group, the 6N group
demonstrated an escalation in ethanol intake following vapor chamber exposure.
Investigation of ethanol-induced behavioral or cognitive deficits will further
characterize the phenotypic differences that may exist as a result of this cyfip2
polymorphism. Although these are two distinct substrains of mice, a group has
created a knock-in of the 6N SNP on a 6J background, making the only
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difference between the two strains the cyfip2 gene, eliminating one of the
variables in these studies (Kumar et al 2013).
Interestingly, in 6N mice, both the water and CIE-exposed groups gained
more weight by the end of the baseline-drinking period compared to 6J mice.
Research in Prader-Willi phenotype, a form of obesity connected with fragile X
syndrome, has implicated Cyfip2 in dysregulation of leptin signaling (Hoeffer et al
2013). Additionally in preclinical obesity studies, 6N mice are prone to develop
diet-induced obesity when given free access to food (Fan et al 2015). Future
studies may investigate whether the genotypic differences in 6J and 6N mice
affect reward choice. Results may reveal an interesting difference in 6N mice
between natural rewards (food) and unnatural rewards (ethanol).
In conclusion, the work presented in this dissertation revealed that chronic
ethanol exposure induces homeostatic alterations in protein translation that likely
occur through modulation of FMRP activity. These alterations in translation were
also accompanied by changes in dendritic spine density and spine morphology.
The aim of these experiments was to examine the role of FMRP in activitydependent, homeostatic protein synthesis in dendrites and dendritic spines in
response to chronic ethanol exposure. Additionally, these studies also
investigated whether spine morphology is associated with these FMRP-mediated
changes in translation and if these two processes have a potential role in
mediating ethanol drinking behaviors. The mechanism driving these neuronal
adaptations during ethanol exposure, and how this may affect behavior is not
well understood. Results from these studies provide evidence of a specific
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mechanism that may be essential for chronic ethanol-induced cellular
adaptations.
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